This is a preview of subscription content, log in via an institution to check access.
Literatur
Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) und Ärztliche Zentralstelle für Qualitätssicherung (äzq). 2001. Das Leitlinien-Manual. Zeitschrift für ärztliche Fortbildung und Qualitätssicherung 95. Jahrgang, Suppl. 1; http://www.uni-duesseldorf.de/AWMF/ll/llmanual.htm.
Statistisches Bundesamt Deutschland. 2006. Gesundheitswesen http://www.destatis.de/basis/d/gesu/gesutab19.php.
Statistisches Bundesamt Deutschland. 2004. Pressemitteilung vom 24. 9. 2004; http://www.destatis.de/presse/deutsch/pm2004/p4060092.htm
de Vreede, J. J., Gorgels, A.P., Verstraaten, G. M., Vermeer, F., Dassen, W.R., and Wellens, H. J. 1991. Did prognosis after acute myocardial infarction change during the past 30 years? A meta-analysis. J Am Coll Cardiol 18:698–706
Fox, K. A. A., Cokkinos, D.V., Deckers, J.W., Keil, U., Maggioni, A.P., and Steg, P. G. 2000. The ENACT study. A pan-European survey of acute coronary syndromes. European network for acute coronary treatment. Eur Heart J 21:1440–1449
Tunstall-Pedoe, H., Kuulasmaa, K., Mahonen, M., Tolonen, H., Ruokokoski, E., and Amouyel, P. 1999. Contribution of trends in survival and coronary-event rates in survival and coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet 353:1547–1557
Löwel, H., Meisinger, C., Heier, M., Hörmann, A., and von Scheidt, W. 2006. Herzinfarkt und koronare Sterblichkeit in Süddeutschland. Ergebnisse des bevölkrungsbasierten MONICA/KORA-Herzinfarktregisters 1991 bis 1993 und 2001 bis 2003. Deutsches Ärzteblatt 103, 10:A616–A622
Lorenz, H., Jünger, C., Seidl, K., Gitt, A., Schneider, S., Schiele, R., Wienbergen, H., Winkler, R., Gottwik, M., Delius, W., Senges, J., and Rauch, B. 2005. Do Statins Influence the Prognostic Impact of Non-Sustained Ventricular Tachycardia After ST-Elevation Myocardial Infarction? Eur Heart J 26:1078–1085
Rauch, B., Schneider, S., Gitt, A., Liebhart, C., Jünger, C., Winkler, R., Schiele, R., Senges, J. on behalf of the ACOS investigators. 2005. Short-term cardiac rehabilitation after myocardial infarction – results from the acute coronary syndrom registry. Eur Heart J. 26 (Abstract Supplement): 503
Wienbergen, H., Gitt, A., Schiele, R., Jünger, C., Heer, T., Gottwik, M., Manthey, J., Hempel, A., Bestehorn, K., Senges, J., Rauch, B., and for the ACOS-study group. 2006. Actual clinical Practice of exercise testing in consecutive patients after non ST-elevation myocardial infarction – results of the acute coronary syndromes registry. Eur J Cardiovasc Prev Rehab 13:457–463
Heer, T., Gitt, A., Jünger, C., Schiele, R., Wienbergen, H., Towae, F., Gottwick, M., Zahn, R., Zeymer, U., Senges, J. 2006. Gender differences in acute non-ST-segment elevation myocardial infarction. Am J Card 98:160–166
Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology, Swedberg, K., Metra, M., Cleland, J., Dargie, H., Drexler, H., Follath, F., Komadja, M., Tavazzi, L., Smiseth, O. A., Gavazzi, A., Haverich, A., Hoes, A., Jaarsma, T., Korewicki, J., Levy, S., Linde, C., Lopez-Sendon, J., Nieminen, M., Pierard, L., and Remme, P. 2005. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 26:1115–1140
Hunt, S. A., Baker, D.W., Chin, M.H., Cinquegrani, M.P., Feldman, A. M., Francis, G. S., Ganiats, T. G., Goldstein, S., Gredoratos, G., Jessup, M.L., Noble, R. J., Packer, M., Silver, M.A., and Stevenson, L.W. 2001. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). Circulation 104:2996–3007
Hoppe, U. C., Erdmann, E., Herausgegeben vom Vorstand der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung. Bearbeitet im Auftrag der Kommission für Klinische Kardiologie in Zusammenarbeit mit der Arzneimittelkommission der Deutschen Ärzteschaft. 2001. Leitlinien zur Therapie der chronischen Herzinsuffizienz. Z Kardiol 90:218–237
Jost, A., Rauch, B., Hochadel, M., Winkler, R., Schneider, S., Jacobs, M., Kilkowski, C., Kilkowski, A., Lorenz, H., Muth, K., Zugck, Ch., Remppis, A., Haass, M., Senges, J., for the HELUMA-Study group. 2005. Beta-blocker treatment of patients with chronic systolic heart failure improves prognosis even in patients meeting one or more exclusion criteria of the MERIT-HF study. Eur Heart J 26:2689–2697
Kuhlmann, E. 2003. Gender Mainstreaming in den Disease Management- Programmen – das Beispiel Koronare Herzerkrankung. Expertise im Auftrag der Bundeskoordination Frauengesundheit, des Arbeitskreises Frauengesundheit, gefördert durch das Bundesministerium für Familie, Senioren, Frauen und Jugend. http://www.zes.uni-bremen.de/~kuhlmann/expertise.pdf
Siegrist, J. 2006. Was trägt die Stressforschung zur Erklärung des sozialen Gradienten koronarer Herzkrankheiten bei? Dtsch med Wschr 131:762-766
Rosengren, A., Hawken, S., Ounpuu, S., Sliwa, K., Zubaid, M., Almahmeed, W. A., Blackett, K. N., Sitthi-Amorn, C., Sato, H., Yusuf, S., for the INTERHEART Investigators. 2004. Association of psychosocial risk factors with risk of acute myocardial infarction in 11,119 cases and 13,648 controls from 52 countries (the INTERHEART study): case-control study. Lancet 364:953–962
SR-Band 209 – Bericht zur gesundheitlichen Situation von Frauen in Deutschland. Eine Bestandsaufnahme unter Berücksichtigung der unterschiedlichen Entwicklung in West- und Ostdeutschland. 2002. Verlag W. Kohlhammer, 3. Auflage. http://www.bmfsfj.de/Kategorien/Forschungsnetz/forschungsberichte, did=4150.html
Heidrich, J., Liese, A.D., Kalic, M., Winter-Enbergs, A., Wellmann, J., Roeder, N., Kerber, S., Breithardt, G., Scheld, H. H., Kleine-Katthöfer, P., Keil, U. 2002. Sekundärprävention der koronaren Herzkrankheit – Ergebnisse der Euroaspire I- und II-Studien in der Region Münster, Germany. Secondary prevention of coronary heart disease. Results from EuroASPIRE I and II in the region Munster, Germany. Deutsche medizinische Wochenschrift 127:667–672
Arzneimittelkommission der deutschen Ärzteschaft. 2003. Deutschland ist Europameister – sowohl bei der Häufigkeit als auch in der mangelhaften Kontrolle des Bluthochdrucks. AkdÄ Newsletter: 040/03
Statistisches Bundesamt Deutschland. 2003. Ergebnisse der Mikrozensus-Befragung; http://www.destatis.de/basis/d/gesu/gesutab7.php
Bergmann, K. E., Mensink, G.B. 1999. Körpermaße und Übergewicht. Gesundheitswesen 61 (Supplement):S115–S120
Benecke, A., Vogel, H. 2006. Übergewicht und Adipositas. Gesundheitsberichterstattung des Bundes. Heft 16. http://www.gbe-bund.de/
Mensink G. 2003. Bundesgesundheits- Survey: Körperliche Aktivität. Beiträge zur Gesundheitsberichterstattung des Bundes. Robert Koch-Institut; ISBN 3-89606-139-9
Rütten, A., Abu-Omar, K., Lampert, T., Ziese, T. 2006. Körperliche Aktivität. Gesundheitsberichterstattung des Bundes, Heft 26. http://www.gbebund.de/
Deutsche Hochdruckliga und Deutsche Hypertonie Gesellschaft.. 2004. Leitlinien für die Prävention, Erkennung, Diagnostik und Therapie der arteriellen Hypertonie AWMF-Leitlinien- Register 046/001; http://www.uni-duesseldorf.de/AWMF/II/ihypto01.htm
Wolf-Maier, K., Cooper, R. S., Banegas, J.R., Giampaoli, S., Hense, H.W., Joffres, M., Kastarinen, M., Poulter, N., Primatesta, P., Rodriguez-Artalejo, F., Stegmayr, B., Thamm, M., Tuomilehto, J., Vanuzzo, D., Vescio, F. 2003. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 289:2363–2369
Wolf-Maier, K., Cooper, J. S., Kramer, H., Banegas, J.R., Giampaoli, S., Joffres, M.R., Poulter, N., Primatesta, P., Stegmayr, B., Thamm, M. 2004. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 43:10–17
Giani, G., Janka, H.U., Hauner, H., Standl, E., Schiel, R., Neu, A., Rathmann, W., Rosenbauer, J. 2005. Epidemiologie und Verlauf des Diabetes mellitus in Deutschland. Evidenzbasierte Leitlinie der DGG – Aktualisierung 05/2004. Hrsg. Scherbaum, W. A., Kiess, W. http://www.deutschediabetes-gesellschaft.de
Standl, E., Eckert, S., Fuchs, C., Horstkotte, D., Janka, H.U., Lengeling, H. G., Petzoldt, R., Redaelli, M., Sawicki, P., Scherbaum, W. A., Strasser, R. H., Tschöpe, D. 2002. Diabetes- Leitlinie (DDG) „Diabetes und Herz“; ISBN 3-936453-08-x
EUROASPIRE II Study Group. 2001. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries, principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J 22:554–572
EUROASPIRE I and II Group and European Action on Secondary Prevention by Intervention to Reduce Events. 2001. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. Lancet 357:995–1001
Rehabilitation und Teilhabe behinderter Menschen. 2004. http://www.bmgs.bund.de/download/gesetze_web/sgb09/sgb09xinhalt.htmSozialgesetzbuch (SGB)Neuntes Buch (IX).
Grande, G., Leppin, A., Romppel, M., Altenhoner, T., Mannebach, H. 2002. Women and men after acute myocardial infarction: are there gender differences in participation rates in cardiac rehabilitation? Rehabilitation 41:320–328
Witt, B. J., Jacobsen, S. J., Weston, S. A., Killian, J. M., Meverden, R. A., Allison, T. G., Reeder, G. S., Roger, V. L. 2004 Cardiac rehabilitation after myocardial infarction in the community. J Am Coll Cardiol 44:988–996
World Health Organisation Expert Committee. 1993. Rehabilitation after cardiovascular diseases, with special emphysis on developping countries. WHO Technical Report Series 831
SIGN (Scottish Intercollegiate Guidelines Network).2002. Cardiac Rehabilitation. A national clinical guideline. SIGN Publication 57
AHCPR (Agency for Health Care Policy and Research).1995. Cardiac Rehabilitation. AHCPR Publication 96-0672, Clinical guideline number 17
NZGG (New Zealand Guidelines Group), New Zealand Heart Foundation. 2002. Evidence-based best practice guideline – cardiac rehabilitation. http://www.nzgg.org.nz/guidelines/0001/cardiac_rehabilitation.pdf
Dietz, R., Rauch, B. 2003. Leitlinie zur Diagnose und Behandlung der chronischen koronaren Herzerkrankung der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung (DGK). In Kooperation mit der Deutschen Gesellschaft für Prävention und Rehabilitation von Herz-Kreislauferkrankungen (DGPR) und der Deutschen Gesellschaft für Thorax-, Herz- und Gefäßchirurgie (DGTHG). Z Kardiol 92:501–521
Jolliffe, J. A., Rees, K., Taylor, R. S., Thompson, D., Oldridge, N., Ebrahim, S. 2004. Exercise-based rehabilitation for coronary heart disease (Cochrane Review). Cochrane Library, Issue 4. http://www.cochrane.org/reviews/
Haskell, W. L., Alderman, E. L., Fair, J. M., Maron, D. J., Mackey, S.F., Superko, H.R., Williams, P.T., Johnstone, I. M., Champagne, M.A., Krauss, R.M. 1999 Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIPT). Circulation 89:975–990
Kotseva, K., Wood, D. A., De Baquer, D., Heidrich, J., De Backer, G., on behalf of the EUROASPIRE II Study Group. 2004. Cardiac rehabilitation for coronary patients: lifestyle, risk factor and therapeutic management. Results from the EUROASPIRE II survey. Eur Heart J, Supplement J:J17–J26
Taylor, R. S., Brown, A., Ebrahim, S., Jolliffe, J., Noorani, H., Rees, K., Skidmore, B., Stone, J. A., Thompson, D.R., Oldridge, N. 2004. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med 116:682–692
Baessler, A., Hengstenberg, C., Holmer, S., Fischer, M., Mayer, B., Hubauer, U., Klein, G., Riegger, G., Schunkert, H. 2001. Long-term effects of in-hospital cardiac rehabilitation on the cardiac risk profile. A casecontrol study in pairs of siblings with myocardial infarction. Eur Heart J 22:1111–1118
Detry, J.R., Vierendeel, I. A., Vanbutsele, R. J., Robert, A.R. 2001. Early short-time intensive cardiac rehabilitation induces positive results as long as one year after acute coronary event: a prospective one-year controlled study. J Cardiovasc Risk 8:355–361
Marchionni, N., Fattirolli, F., Fumagalli, S., Oldridge, N., Del Lungo, F., Morosi, L., Burgisser, C., Masotti, G. 2003. Improved exercise tolerance and quality of life with cardiac rehabilitation of older patients after myocardial infarction: results of a randomized, controlled trial. Circulation 107:2201–2206
Willich, S. N., Müller-Nordhorn, J., Kullig, J., Binting, S., Gohlke, H., Hahmann, H., Bestehorn, K., Krobot, K., Völler, H., for the PIN Study Group. 2001. Cardiac risk factors, medication, and recurrent clinical events after acute coronary disease. A prospective cohort study. Eur Heart J 22:307–313
DeWood, M. A., Stifter, W.F., Simpson, C. S., Spores, J., Eugster, G. S., Judge, T.P., Hinnen, M.L. 1986. Coronary arteriographic findings soon after non-Q-wave myocardial infarction. N Engl J Med 315:417–423
Bertrand, M.E., Simoons, M.C., Fox, K. A. A., Wallentin, L. C., Hamm, C.W., McFadden, E., DeFeyter, P. J., Speccia, G., Ruzyllo, W. 2002. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. The Task Force on the Management of Acute Coronary Syndromes of the European Society of Cardiology. Eur Heart J 23:1809–1840
Heidrich, J., Liese, A.D., Kalic, M., Winter-Enbergs, A., Wellmann, J., Roeder, N., Kerber, S., Breithardt, G., Scheld, H. H., Kleine-Katthöfer, P., Keil, U. 2002. Sekundärprävention der koronaren Herzkrankheit – Ergebnisse der EuroASPIRE I- und II-Studien in der Region Münster, Germany. Secondary prevention of coronary heart disease. Results from EuroASPIRE I and II in the region Munster, Germany. Deutsche Medizinische Wochenschrift 127:667–672
Vaccarino, V., Krumholz, H. M., Yarzebski, J., Gore, J. M., Goldberg, R. J. 2001. Sex-differences in 2-year mortality after hospital discharge for myocardial infarction. Ann Intern Med 134:173–181
Hedbäck, B., Perk, J., Hörnblad, M., Ohlsson, U. 2001. Cardiac rehabilitation after coronary artery bypass surgery: 10-year results on mortality, morbidity and readmission to hospital. J Cardiovasc Risk 8:153–158
Wright, D. J., Williams, S. G., Riley, R., Marshall, P., Tan, L. B. 2004. Is early, low level, short term exercise cardiac rehabilitation following coronary bypass surgery beneficial? A randomized controlled trial. Heart 88:83–84
Simchen, E., Naveh, I., Zitser-Gurevich, Y., Brown, D., Galai, N. 2001. Is participation in cardiac rehabilitation programs associated with better quality of life and return to work after coronary artery bypass operations? The Israeli CABG Study. The Israel Medical Association J 3:399–403
Engblom, E, Korpilahti, K., Hämäläinen, H., Puukka, P., Ronnemaa, T. 1996. Effects of five years of cardiac rehabilitation after coronary artery bypass grafting on coronary risk factors. Am J Cardiol 78:1428–1431
Engblom, E., Korpilahti, K., Hamalainen, H., Ronnemaa, T., Puukka, P. 1997. Quality of life and return to work 5 years after coronary artery bypass surgery. J Cardiopulm Rehab 17:29–36
Pasquali, S. K., Alexander, K.P., Coombs, L.P., Lytle, B. L., Peterson, E.D. 2003. Effect of cardiac rehabilitation on functional outcomes after coronary revascularization. Am Heart J 145:445–451
Belardinelli, R., Paolini, I., Cianci, G., Piva, G., Georgiou, D., Purcaro A. 2001. Exercise training intervention after coronary angioplasty: the ETICA trial. J Am Coll Cardiol 37:1891–1900
Higgins, H. C., Hayes, R. L., McKenna, K.T. 2001. Rehabilitation outcomes following percutaneous coronary interventions (PCI). Patient education and counseling 43:219–130
Hofman-Bang, C., Lisspers, J., Nordlander, R., Nygren, A., Sundin, O., Ohman, A., Ryden, L.. 1999. Two-year results of a controlled study of residential rehabilitation for patients treated with percutaneous transluminal coronary angioplasty. A randomized study of a multifactorial programme. Eur Heart J 20:1465–1474
Kotseva, K., Tuniz, D., Bernardi, G., Molinis, G., Valente, M., Dòdrico, N., Mirolo, R., Morocutti, G., Spedicato, L., Fioretti, P.M. 2004. Ambulatory cardiac rehabilitation with individualized care after elective coronary angioplasty: one year outcome. Eur Heart J, Supplement J: J37–J46
Hasdai, D., Garrat, K. N., Grill, D. E., Lerman, A., Holmes, D.R. Jr. 1997. Effect of smoking status on the longterm outcome after successful percutaneous coronary revascularization. New Engl J Med 336:755–761
Cho, L., Bhatt, D. L., Wolski, K., Lincoff, M., Topol, E. J., Moliterno, D. J. 2001. Effect of smoking status and abciximab use on outcome after percutaneous coronary revascularization: pooled analysis from EPIC, EPILOG, and EPISTENT. Am Heart J 141:599–602
Saia, F., de Feyter, P., Serruys, P.W., Lemos, P. A., Arampatzis, C. A., Hendrickx, G.R., Delarche, N., Goedhart, D., Lesaffre, E., and Branzi, A. 2004. Effect of fluvastatin on long-term outcome after coronary revascularization with stent implantation. Am J Cardiol 93:92–95
Bropy, J. M., Bourgault, C., and Brassard, P. 2003. The use of cholesterol-lowering medicatios after coronary revascularization. CMAJ 169:1153–1157
Flaker, G. C., Warinca, J.W., Sacks, F. M., Moye, L. A., Davis, B.R., Rouleau, J. L., Webel, R.R., Pfeffer, M. A., and Braunwald, E. 1999. Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations. J Am Coll Cardiol 34:106–112
Carlsson, R. 1998. Serum Cholesterol, lifestyle, working capacity and quality of life in patients with coronary artery disease. Experiences from a hospital-based secondary prevention programme. Scandinavian Cardiovascular J 50:1–20
Ornish, D., Scherwitz, L.W., Billings, J. H., Brown, S. E., Gould, K. L., Merrit, T. A., Sparler, S., Armstrong, W.T., Prots, T. A., Kirkeide, R. L., Hogeboom, C., Brand, R. J. 1998. Intensive lifestyle changes for reversal of coronary artery disease. JAMA 280:643–647
Hambrecht, R., Walther, C., Möbius- Winkler, S., Gielen, S., Linke, A., Conradi, K., Erbs, S., Kluge, R., Kendziorra, K., Sabri, O., Sick, P., and Schuler, G. 2004. Percutaneous Coronary Angioplasty Compared With Exercise Training in Patients With Stable Coronary Artey Disease – A Randomized Trial. Circulation 109:1371–1378
Gutenbrunner, Ch., Schreiber, C., Beck, K., Walter, N., Ehlebracht-König, I., von Pezold, E., Gehrke, A., Kniesch, K., Thon, B., and Candir, F. 2002. Prospektive kontrollierte Studie über die Langwirksamkeit stationärer Heilverfahren auf das kardiovaskuläre Risikoprofil. Phys Med Rehab Kuror 12:272–283
Schuler, G., Hambrecht, R., Schlierf, G., Niebauer, J., Hauer, K., Neumann, J., Hoberg, E., Drinkmann, A., Bacher, F., Grunze, M., Kübler, W. 1992. Regular physical exercise and low-fat diet: effects of progression of coronary artery disease. Circulation 86:1–11
Niebauer, J., Hambrecht, R., Velich, Z., Hauer, K., Marburger, C., Kälberer, B., Weiss, C., von Hodenberg, E., Schlierf, G., Schuler, G., Zimmermann, R., Kübler, W. 1997. Attenuated progression of coronary artery disease after 6 years of multifactoral risk intervention. Role of physical exercise. Circulation 96:2534–2541
Buchwalsky, G., Buchwalsky, R., and Held, K. 2002. Langzeitwirkungen der Nachsorge in einer ambulanten Herzgruppe. Eine Fall-/Kontrollstudie. Z Kardiol 91:139–146
Hemingway, H., McCallum, A., Shipley, M., Manderbacka, K., Martikainen, P., and Keskimäki, I. 2006. Incidence and prognostic implications of stable angina pectoris among women and men. JAMA 295:1404–1411
Daly, C., Clemens, F., Lopez-Sendon, J. L., Tavazzi, L., Boersma, E., Danchin, N., Delahaye, F., Gitt, A., Julian, D., Milcahy, D., Ruzyllo, W., Thygesen, K., Verheugt, F., and Fox, K.M. 2006. Gender differences in the management and clinical outcome of stable angina. Circulation 113:490–498
Belardinelli, R., Georgiou, D., Cianci, G., and Purcaro, A.1999. Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome. Circulation 99:1173–1182
Hambrecht, R., Niebauer, J., Fiehn, E., Kälberer, B., Offner, B., Hauer, K., Riede, U., Schlierf, G., Kübler, W., and Schuler, G. 1995. Physical Training in Patients with Stable Chronic Heart Failure: Effects on Cardiorespiratory Fitness and Ultrastructural Abnormalities of Leg Muscles. J Am Coll Cardiol 25:1239–1249
Hambrecht, R., Gielen, S., Linke, A., Fiehn, E., Yu, J., Walther, C., Schoene, N., and Schuler, G. 2000. Effects of Exercise Training on Left ventricular Function and Peripheral Resistance in Patients with Chronic Heart Failure – a Randomized Trial. JAMA 283:3095–3101
Wielenga, R.P., Huisveld, I. A., Bol, E., Dunselman, P. H. J. M., Erdman, R. A. M., Baselier, M.R.P., and Mosterd, W. L. 1999. Safety and effects of physical training in chronic heart failure. Results of the Chronic Heart Failure and Graded Exercise study (CHANGE). Eur Heart J 20:872–879
Rees, K., Taylor, R. S., Singh, S., Coats, A. J. S., and Ebrahim, S. 2004. Exercise based rehabilitation for heart failure (Cochrane Review).The Cochrane Library 4; http://www.cochrane.org/cochrane/revabstr/AB003331.htm.
Whellan, D. J., Shaw, L. K., Bart, B. A., Kraus, W. E., Califf, R. M., and O'Connor, C.M. 2004. Cardiac rehabilitation and survival in patients with left ventricular systolic dysfunction. Am Heart J 142.:160–166
Piepoli, M.F., Davos, C., Francis, D.P., Coats, A. J. S., and ExtraMATCH Collaborative. 2004. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTra- MATCH). Brit Med J 328:189–195
Hanumanthu, S., Butler, J., Chomsky, D., Davis, S., and Wilson, J.R. 1997. Effect of a Heart Failure Program on Hospitalization Frequency and Exercise Tolerance. Circulation 96:2842–2848
Stewart, S., Marley, J. E., and Horowitz, J.D. 1999. Effects of a multidisciplinary, home-based intervention on unplanned readmissions and survival among patients with chronic congestive heart failure: a randomized controlled study. Lancet 354:1077–1083
West JA, Miller NH, Parker KM, Senneca D, Ghandour G, Clark M, Greenwald G, Heller RS, Fowler MB, DeBusk RF. 1997. A comprehensive management system for heart failure improves clinical outcomes and reduces medical resource utilization. Am J Cardiol 79:58–63
Gonseth, J., Guallar-Castillon, P., and Banegas, J.R. 2004. The effectiveness of disease management programmes in reducing hospital re-admission in older patients with heart failure: a systematic review and meta-analysis of published reports. Eur Heart J 25:1570–1595
Capomolla, S., Febo, O., Ceresa, M., Caporotondi, A., Guazzotti, G., La Rovere, M., Ferrari, M., Lenta, F., Baldin, S., Vaccarini, C., Gnemmi, M., Pinna, G., Maestri, R., Abelli, P., Verdirosi, S. Cobelli, F. 2002. Cost/utility ratio in chronic heart failure: comparison between heart failure management program delivered by dayhospital and usual care. J Am Coll Cardiol 40:1259–1266
Rich, M.W. Beckham, V., Wittenberg, C., Leven, C. L., Freedland, K. E., and Carney, R.M. 1995. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 333:1190–1195
Erhardt, L.R. and Cline, C.M. 1998. Organisation of the care of patients with heart failure. Lancet 352 Suppl 1: S115–S118
Naylor, M.D., Brooten, D., Campbell, R., Jacobsen, B. S., Mezey, M.D., Pauly, M.V., Schwartz, J. S. 1999. Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized clinical trial. JAMA 281:613–620
Rich, M.W. 1999. Heart failure disease management: a critical review. J Card Fail 5:64–75
McAlister, F. A., Lawson, F. M., Teo, K. K., and Armstrong, P.W. 2001. A systematic review of randomized trials of disease management programs in heart failure. Am J Med 110:378–384
Krumholz, H. M., Amatruda, J., Smith, G. L., Mattera, J. A., Roumanis, A. A., Radford, M.J., Crombie, P., Vaccarino, V. 2002. Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. J Am Coll Cardiol 39:83–89
Blue, L., Lang, E., McMurray, J. J., Davie, A.P., McDonagh, T. A., Murdoch, D.R., Petrie, M.C., Connolly, E., Norrie, J., Round, C. E., Ford, I., Morrison, C. E. 2001. Randomised controlled trial of specialist nurse intervention in heart failure. BMJ 323:715–718
Riegel, B., Carlson, B., Kopp, Z., Le- Petri, B., Glaser, D., and Unger, A. 2002. Effect of a standardized nurse case-management telephone intervention on resource use in patients with chronic heart failure. Arch Intern Med 162:705–712
Reibis, R., Dovifat, C., Dissmann, R., Ehrlich, B., Schulz, S., Stolze, K., Wegscheider, K., and Völler, H. 2006. Implementation of evidence-based therapy in patients with systolic heart failure from 1998-2000. Clin Res Cardiol 95:154–161
Posival, H. 2001. Frührehabilitation nach Herzoperation: welche Erwartungen hat der Herzchirurg? In: Der schwerkranke und multimorbide Herzpatient – eine Herausforderung für die kardiologische Rehabilitation. Rauch, B., Held, K. Hrsg. Steinkopff Darmstadt, ISBN 3-7985-1323-6:98–103
Butchart, E., Gohlke-Bärwolf, C., Antunes, M.J., Tornos, P., De Caterina, R., Cormier, B., Prendergast, B., Lung, B., Bjornstad, H., Leport, C., Hall, R. J., Vahanian, A., and Working Groups on Valvular Heart Disease, Thrombosis and Cardiac Rehabilitation and Exercise Physiology European Society of Cardiology. 2005. Recommendations for the management of patients after heart valve surgery. Eur Heart J 26:2453–2471
Gohlke-Bärwolf, C. and Gohlke, H. 2004. Allgemeine Untersuchung und Behandlung vor und nach herzchirurgischen Eingriffen. Herzkrankheiten – Pathophysiologie, Diagnostik, Therapie. Roskamm, H., Neumann, F.-J., Kalusche, D., Bestehorn, H.-P. Hrsg. 5. Auflage: 1087–1096
Douard, H., Chevalier, L., Labbe, L., Choussat, A., Broustat, J.P. 1997. Physical training improves exercise capacity in patients with mitral stenosis after balloon valvuloplasty. Eur Heart J 18:464–469
Landry, F., Habel, C., Desaulniers, D., Dagenais, G.R., Moisan, A., and Cote, L. 1984. Vigorous physical training after aortic valve replacement: analysis of 10 patients. Am J Cardiol 53:562–566
Jairath, N., Salerno, T., Chapman, J., Dornan, J., and Weisel, R. 1995. The effect of moderate exercise training on oxygan uptake post-aortic-mitral valve surgery. J Cardiopulm Rehabil 15:424–430
Newell, J.P., Kappagoda, C.T., Stoker, J. B., Deverall, P. B., Watson, D. A., and Linden, R. J. 1980. Physical training after heart valve replacement. Br Heart J 44:638–649
Toyomasu, K., Nishiyama, Y., Yoshida, N., Sugimoto, S., Noda, T., Motonaga, I., Koga, Y., and Toshima, H. 1990. Physical training in patients with valvular heart disease after surgery. Jpn Circ J 54:1451–1458
Sire, S. 1987. Physical training and occupational rehabilitation after aortic valve replacement. Eur Heart J 8:1215–1220
Gohlke-Bärwolf, C., Gohlke, H., Samek, L., Peters, K., Betz, P., Eschenbruch, E., Roskamm, H. 1992. Exercise tolerance and working capacity after valve replacement. J Heart Valve Disease 1:189–195
Habel-Verge, C., Landry, F., Desaulniers, D., Dagenais, G.R., Moisan, A., Coté, L., Robitaille, N.M. 1987. L'entrainement physique apres un remplacement valvulaire mitral. Can Med Ass J 136:142–147
Ueshima, K., Kamata, J., Kobayashi, N., Saito, M., Sato, S., Kawazoe, K., Hiramori, K. 2004. Effects of exercise training after open heart surgery on quality of life and exercise tolerance in patients with mitral regurgitation or aortic regurgitation. Jpn Heart J:789–797
Vanhees, L., Stevens, A. N., Schepers, D., Defoor, J., Rademakers, F., Fagard, R. 2004. Determinants of the effects of physical training and of the complications requiring resuscitation during exercise in patients with cardiovascular disease. Eur J Cardiovasc Prev Rehabil 11:304–312
Meurin, P., Iliou, M. C., Ben Driss, A. B., Pierre, B., Corone, S., Cristofini, P., Tabet, J.Y., Working Group of Cardiac Rehabilitation of the French Society of Cardiology. 2005. Early exercise training after mitral valve repair: a multicentric prospective French study. Chest 128:1638–1644
Körtke, H., Gohlke-Bärwolf, C., Heik, S. C.W., Horstkotte, D., Körfer, R., Herausgegeben vom Vorstand der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung, bearbeitet im Auftrag der Kommission für Klinische Kardiologie. 1998. Empfehlungen zum INR-Selbstmanagement bei oraler Antikoagulation. Z Kardiol 87:983–985
Kavanagh, T., Yacoub, M. H., Mertens, D. J., Kennedy, J., Campbell, R. B., and Sawyer, P. 1988. Cardiorespiratory responses to exercise training after orthotopic cardiac transplantation. Circulation 77:162–171
Niset, G., Hermanns, L., and Depelchin, P. 1991. Exercise and heart transplantation: a review. Sports Med 12:359–379
Kobashigawa, J. A., Leaf, D. A., Lee, N., Gleeson, M.P., Liu, H. H., Hamilton, M.A., Moriguchi, J.D., Kawata, N., Einhorn, K., Herlihy, E., and Laks, H. 1999. A controlled trial of exercise rehabilitation after heart transplantation. N Engl J Med 340:272–277
Shumway SJ, Shumway NF, Calow P, Sibley R. 1995. Thoracic Transplantation. Blackwell Science Inc., ISBN-10: 0865422858; ISBN-13: 978-865422858
Scheld, H. H., Deng, M. C., Hammel, D., und Schmid, C. 2000. Leitfaden Herztransplantation. Interdisziplinäre Betreuung vor, während und nach Herztransplantation. Steinkopff Darmstadt, ISBN 3-7985-1224-8
Hohnloser, S. H., Andresen, D., Block, M., Breithardt, G., Jung, W., Klein, H., Kuck, K. H., Lüderitz, B., und Steinbeck, G. 2000. Leitlinien zur Implantation von Defibrillatoren. Z Kardiol 89:126–135
Lewin, R. J., Frizelle, D. J., and Kaye, G. C. 2001. A rehabilitation approach to patients with internal cardioverter-defibrillators. Heart 85:371–372
Vanhees, L., Kornaat, M., Defoor, J., Aufdemkampe, G., Schepers, D., Stevens, A., Van Exel, H., Van den Beld, J., Heidbüchel, H., and Fagerd, R. 2004. Effect of exercise training in patients with an implantable cardioverter defibrillator. Eur Heart J 25:1120–1126
Van de Werf, F., Ardissino, D., Betriu, A., Cokkinos, D.V., Falk, E., Fox, K. A. A., Julian, D., Lengyel, M., Neumann, F. J., Ruzyllo, W., Thygesen, C., Underwood, S.R., Vahanian, A., Verheugt, F.W. A., and Wijns, W. 2003. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 24:28–66
Eagle, K. A., Lim, M.J., Dabbous, O. H., Pieper, K. S., Goldberg, R. J., Van de Werf, F., Goodman, S. G., Granger, C. B., Steg, P. G., Gore, J. M., Budaj, A., Avezum, A., Flather, M.D., Fox, K. A. A., for the GRACE Investigators. 2004. A validated prediction model for all forms of acute coronary syndrome – estimating the risk of 6-month postdischarge death in an international registry. JAMA 291:2727–2733
Hochmann, J. S., Tamis, J. E., Thompson, T.D., Weaver, W.D., White, H.D., Van de Werf, F., Aylward, P., Topol, E. J., Califf, R. M., for the Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes II b Investigators. 1999. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. N Engl J Med 341:226–232
De Backer, G., Ambrosioni, E., Borch- Johnson, K., Brotons, C., Cifkova, R., Dallongeville, J., Ebrahim, S., Faergeman, O., Graham, I., Mancia, G., Cats, V. M., Orth-Gomer, K., Perk, J., Pyörälä, K., Rodicio, J. L., Sans, S., Snasoy, V., Sechtem, U., Silber, S., Thomsen, T., and Wood, D.; Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice. 2003. European guidelines on cardiovascular disease prevention in clinical practice. European J Cardiovasc Prev Rehabil 10 (Suppl 1): S1–S78
Deutsche Gesellschaft für Prävention und Rehabilitation von Herz-Kreislauferkrankungen (DGPR). 2000. Empfehlungen zu Standards der Prozessqualität in der kardiologischen Rehabilitation (Teil I). Herz Kreislauf 32:141–145
Shumaker SA, Brooks, MM, Schron EB, Hale C, Kellen JC, Inkster M, Wimbush FB, Wiklund I, Morris M. 1997. Gender differences in healthrelated quality of life among postmyocardial infarction patients: brief report. CAST Investigators Cardiac Arrhythmia Suppression Trials. Woman's Health 3:53–60
Deshotels, A., Planchock, N., Dech, Z., Prevost, S. 1995. Gender differences in perceptions of quality of life in cardiac rehabilitation patients. J Cardiopulm Rehabil 15:143–148
Regitz-Zagrosek, V., Lehmkuhl, E., and Weickert, M.O. 2006. Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clin Res Cardiol 95:136–147
Abramov, D., Tamariz, M.G., Sever, J.Y., Christakis, G.T., Bhatnagar, G., Heenan, A. L., Goldman, B. S., and Fremes, S. E. 2000. The influence of gender on the outcome of coronary artery bypass surgery. The Annals of Thoracic Surgery 70:800–805
Vaccarino, V., Lin, Z. Q., Kasl, S.V., Mattera, J. A., Roumanis, S. A., Abramson, J. L., Krumholz, H.M. 2003. Sex differences in health status after coronary artery bypass surgery. Circulation 108:2642–2647
Jochmann, N., Stangl, K., Garbe, E., Baumann, G., and Stangl, V. 2005. Female- specific aspects in the pharmacotherapy of chronic cardiovascular diseases. Eur Heart J 26:1585–1595
Huxley, R., Barzi, F., Woodward, M. 2006. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. Brit Med J 332:73–78
Härtel, U. 2002. Krankheiten des Herz-Kreislaufsystems. In: Hurrelmann et al. (Hrsg.) Handbuch Geschlecht – Gesundheit – Krankheit. Hans Huber, Bern. 273–290
Deutsche Gesellschaft für Prävention und Rehabilitation von Herz-Kreislauferkrankungen. 2000. Empfehlungen zu Standards der Prozessqualität in der kardiologischen Rehabilitation (Teil 2). Herz Kreislauf 32:294–297
Deutsche Gesellschaft für Prävention und Rehabilitation von Herz-Kreislauferkrankungen (DGPR). 2000. Empfehlungen zu Standards der Prozessqualität in der kardiologischen Rehabilitation (Teil 3). Herz Kreislauf 32:378–380
Deutsche Gesellschaft für Prävention und Rehabilitation von Herz-Kreislauferkrankungen (DGPR). 2002. Empfehlungen zu Standards der Prozessqualität in der kardiologischen Rehabilitation (Teil 4). Z Kardiol 91:99–102
Blair, S. N., Kampert, J. B., Kohl, H.W. III., Barlow, C. E., Macera, C. A., Paffenberger, R. S. Jr., et al. 1996. Influences of cardiorespiratory fitness and other percursors on cardiovascular disease and all-cause mortality in men and women. JAMA 276:205–210
Sandvik, L., Erikssen, J., Thaulow, E., Erikssen, G., Mundal, R., and Rodahl, K. 1993. Physical fitness as a predictor of mortality among healthy, middle aged Norwegian men. New Engl J Med 328:533–537
Blair, S.N. and Jackson, A. S. 2001. Physical fitness and activity as separate heart disease risk factors: a meta-analysis. Med Sci Sports Exerc 33:762–764
Myers, J., Prakash, M., Fröhlicher, V., Do, D., Partington, S., Atwood, J. E. 2002. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 346:793–801
Slattery, M.L., Jacobs, D.R., and Nichaman, Z.M. 2001. Leisure time physical activity and coronary heart disease death; the U. S. railroad study. Circulation 79:304–311
Manson, J.F., Hu, J., Rich-Edwards. 1999. A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women. New Engl J Med 341:650–658
Laukkanen, J. A., Lakka, T. A., Rauramaa, R., Kuhanen, R., Venäläinen, J. M., Salonen, R., Salonen, J.T. 2001. Cardiovascular fitness as a predictor of mortality in men. Arch Intern Med 161:825–831
Leon, A. S., Franklin, B. A., Costa, F., Balady, G. J., Berra, K. A., Stewart, K. J., Thompson, P.D., Williams, M.A., and Lauer, M.S. 2005. Cardiac Rehabilitation and Secondary Prevention of Coronary Heart Disease. An American Heart Associations Scientific Statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity), in Collaboration with the American Association of Cardiovascular and Pulmonary Rehabilitation. Circulation 111:369–376
Fletcher, G.F., Balady, G. J., Amsterdam, E. A., Chaitman, B., Eckel, R., Fleg, J., Fröhlicher, V.F., Leon, A. S., Pina, I. L., Rodney, R., Simons-Morton, D. A., Williams, M.A., Bazzarre, T. 2001. Exercise standards for testing and training: a statement for healthcare professionals from the American Heart Association. Circulation 104:1694–1740
Bjarnason-Wehrens, B., Mayer-Berger, W., Meister, E.R., Baum, K., Hambrecht, R., Gielen, S. 2004. Einsatz von Kraftausdauertraining und Muskelaufbautraining in der kardiologischen Rehabilitation. Empfehlungen der Deutschen Gesellschaft für Prävention und Rehabilitation von Herz- Kreislauferkrankungen. Z Kardiol 93:357–370
Adams, J., Cline, M.J., Hubbard, M., McCullough, T., Hartman, J. 2006. A new paradigm for post-cardiac event resistance exercise guidelines. Am J Cardiol 97:281–286
Mittleman, M.A., Maclure, M., Tofler, G. H., Sherwood, J. B., Goldberg, R. J., Muller, J.E. 1993. Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. Determinants of Myocardial Infarction Onset Study Investigators. New Engl J Med 329:1677–1683
Albert, C. M., Mittleman, M.A., Chae, C.U., Lee, I. M., Hennekens, C. H., Manson, J. E. 2000. Triggering of sudden death from cardiac causes by vigorous exertion. New Engl J Med 343:1355–1361
Willich, S. N., Lewis, M., Lowel, H., Arntz, H.R., Schubert, F., and Schroder, R. 1993. Physical exertion as a trigger of acute myocardial infarction. Triggers and Mechanisms of Myocardial Infarction Study Group. N Engl J Med 329:1684–1690
Ades, P. A. 2001. Cardiac rehabilitation and secondary prevention of coronary heart disease. New Engl J Med 345:892–902
Dugmore, L.D., Tipson, R. J., Phillips, M.H., Flint, E. J., Stentiford, N. H., Bone, M.F., and Littler, W.A. 1999. Changes in cardiorespiratory fitness, psychological wellbeing, quality of life, and vocational status following a 12 month cardiac exercise rehabilitation programme. Heart 81:359–366
Ades, P. A., Waldsmann, M.L., Meyer, W. L., Brown, K. A., Poehlman, E.T., Pendlebury, W.W., Leslie, K.O., Gray, P.R., Lew, R.R., Le Winter, M.M. 1996. Skeletal muscle and cardiovascular adaptations to exercise conditioning in older coronary patients. Circulation 94:323–330
Kavanagh, T., Mertens, D. J., Hamm, L.F., Beyene, J., Kennedy, J., Corey, P., and Shepard, R. J. 2002. Prediction of long-term prognosis in 12 169 men referred for cardiac rehabilitation. Circulation 106:666–671
Kavanagh, T., Mertens, D. J., Hamm, L.F., Beyene, J., Kennedy, J., Corey, P., and Shepard, R. J. 2003. Peak oxygen intake and cardiac mortality in women referred for cardiac rehabilitation. J Am Coll Cardiol 42:2139–2143
Karoff, M., Roseler, S., Lorenz, C., und Kittel, J. 2000. Intensivierte Nachsorge (INA) – ein Verfahren zur Verbesserung der beruflichen Reintegration nach Herzinfarkt und/oder Bypassoperation. Z Kardiol 89:423–433
Pescatello, L. S., Franklin, B. A., Fagard, R., Farquhar, W. B., Kelly, G. A., Ray, C. A. 2004. American College of Sports Medicine Positions Stand: Exercise and Hypertension. Med Sci Sports Exerc 36:533–553
Whelton, S.P., Chin, A., Xin, X., He, J. 2002. Effect of aerobic exercise on blood pressure: a metaanalysis of randomized, controlled trials. Ann Intern Med 136:493–503
Cornelissen, V. A., Fagard, R.H. 2005. Effects of endurance training on blood pressure, blood pressure-regulating mechanisms, and cardiovascular risk factors. Hypertension 46:667–675
Garrow, J. S. and Summerbell, C.D. 2004. Meta-Analysis of Exercise, with or without dieting, on the body composition of owerweight subjects. Diabetes Metab Res Rev 20:383–393
Miller, W. C., Koceja, D. M., and Hamilton, E. J. 2005. A meta-analysis of the past 25 years of weight loss research using diet, exercise or diet with exercise intervention. Int J Obes 21:941–947
Jakicic, J. M., Winters, C., Lang, W., Wing, R.R. 1999. Effects of intermittent exercise and use of home exercise equipment on adherence, weight loss and fitness in overweight women. JAMA 282:1554–1560
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T.T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., Salminen, V., Uusitupa, M. 2001. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New Engl J Med 344:1343–1350
Boule, N. G., Haddad, E., Kenny, G.P., Wells, G. A., Sigal, R. J. 2001. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. JAMA 286:1218–1227
Pan, X.R., Li, G.W., Hu, Y. H., Wang, J. X., Yang, W.Y., An, Z. X., Hu, Z. X., Lin, J., Xiao, J. Z., Cao, H. B., Liu, P. A., Jiang, X. G., Jiang, Y.Y., Wang, J.P., Zheng, H., Zhang, H., Bennet, P. H., and Howard, B.V. 1997. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20:537–544
Leon, A. S., Rice, T., Mandel, S., Deprés, J.P., Bergeron, J., Gagnon, J., Rao, D. C., Skinner, J. S., Wilmore, J. H., Bouchard, C. 2000. Blood lipid response to 20 weeks of supervised exercise in a large biracial population: the HERITAGE Family Study. Metabolism 49:513–520
Leon, A. S. and Sanchez, O. A. 2001. Response of blood lipids to exercise training alone or combined with dietary intervention. Med Sci Sports Exerc 33: S502–S515
Prisco, D., Francalani, L., Filippini, M., Hagi, M. I. 1994. Physical exercise and haemostasis. Int J Clin Lab Res 24:125–131
Hambrecht, R., Wolff, A., Gielen, S., Linke, A., Hofer, J., Erbs, S., Schoene, N., Schuler, G. 2000. Effect of exercise on coronary endothelial function in patients with coronary artery disease. New Engl J Med 342:454–460
Niebauer, J., Hambrecht, R., Marburger, C., Hauer, K., Velich, T., von Hodenberg, E., Schlierf, G., Kübler, W., Schuler, G. 1995. Impact of intensive physical exercise and low fat diet on collateral vessel formation in stable angina pectoris and angiographically confirmed coronary artery disease. Am J Cardiol 76:771–775
Laufs, U., Werner, N., Link, A., Endres, M., Wassmann, S., Jürgens, K., Miche, E., Böhm, M., Nickering, G. 2004. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 109:220–226
Hambrecht, R., Niebauer, J., Marburger, C. 1993. Various intensities of leisure time physical activity in patients with coronary artery disease: effects on cardiorespiratory fitness and progression of atherosclerotic lesions. J Am Coll Cardiol 22:468–477
Hambrecht, R., Fiehn, E., Weigl, C., Gielen, S., Hamann, C., Kaiser, R., Yu, J., Adams, V., Niebauer, J., and Schuler, G. 1998. Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 98:2709–2715
Bravo, G., Gauthier, P., Roy, P. M., Payette, H., Gaulin, P., Harvey, M., Péloquin, L., Dubois, M.F. 1996. Impact of a 12-Month Exercise Program on the Physical and Psychological health of Osteopenic Women. American Geriatrics Society 44:756–762
Revel, M., Mayons-Benhamon, M.A., Rabourdin, J.P., Bagheri, F., Roux, C. 1993. One year training can prevent lumbar bone loss in postmenopausal women; a randomizied controlled trial. Calcif Tissue Int 53:307–311
Pratley, R., Nicklas, B., and Rubin, M. 1994. Strength training increases resting metabolic rate and norepinephrine levels in healthy 50- to 65-year-old men. J Appl Physiol 76:133–137
Fluckey, J.D., Hickey, M. S., Brambrink, J. K., Hart, K. K., Alexander, K., Craig, B.W. 1994. Effects of resistance exercise on glucose tolerance in normal and glucose-intolerant subjects. J Appl Physiol 77:1087–1092
Smutok, M.A., Reece, C., Kokkinos, P.F., Farmer, C. M., Dawson, P. K., De-Vane, J., Patterson, J., Goldberg, A.P., Hurley, B.F. 1994. Effects of exercise training modality on glucose tolerance in men with abnormal glucose regulations. J Sports Med 15:283–289
Kohl, H.W., Powell, K. E., Gordon, N.F., Blair, S. N., and Paffenberger, R. S. 1992. Physical activity, physical fitness, and sudden cardiac death. Epidemiol Rev 14:37–58
Haskell, W. L. 1994. The efficacy and safety of exercise programs in cardiac rehabilitation. Med Sci Sports Exerc 26:815–823
Franklin, B. A., Bonzheim, K., Gordon, S., Timmis, G. C. 1998. Safety of medically supervised outpatient cardiac rehabilitation exercise therapy: a 16–year follow-up. Chest 114:902–906
Smart, N. and Marwick, T. H. 2004. Exercise training for patients with heart failure: a systematic review of factors that improve mortality and morbidity. Am J Med 116:693–706
Van Camp, S.P., Peterson, R. A. 1986. Cardiovascular complications of outpatient cardiac rehabilitation programs. JAMA 256:1160–1163
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). 2001. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). JAMA 285:2486–2497
Gohlke, H., Kübler, W., Matthes, P., Meinertz, T., Schuler, G., Gysan, D.R., Sauer, G. 2001. Empfehlungen zur umfassenden Risikoverminderung für Patienten mit koronarer Herzkrankheit und Diabetes. Z Kardiol 90:148–149
Grundy, S. M., Cleeman, J. L., Merz, C. N. B., Brewer, H. B., Clark, L.T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., Stone, N. J., and for the Coordinating Committee of the National Cholesterol Education Program. 2004. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 110:227–239
Stamler, J., Wentworth, D., and Neaton, J.D. 1986. Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continous and graded? Findings in 356 222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 256:2823–2828
Verschuren, W. M., Jacobs, D.R., Bloemberg, B.P., Kromhout, D., Menotti, A., Aravanis, C., Blackburn, H., Buzina, R., Dontas, A. S., Fidenza, F., Karvonen, M.J., Nedeljkonviv, S., Nissinen, A., and Toshima, H. 1995. Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. JAMA 274:131–136
Cullen, P., Funke, H., Schulte, H., Assmann, G. 1998. Lipoproteins and cardiovascular risk – from genetics to CHD prevention. Eur Heart J 19 (Suppl C): C5–C11
Manninen, V., Tenkannen, L., Koskinen, P., Huttunen, J. K., Mänttäri, M., Heinonen, O.P., Frick, M.H. 1992. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Circulation 85:37–45
Jeppesen, J., Hein, H.O., Suadicani, P., and Gyntelberg, F. 1998. Triglyceride concentration and ischaemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation 97:1029–1036
Halle, M., Berg, A., Garwers, U., Baumstark, M.W., Knisel, W., Grathwohl, D., König, D., Keul, J. 1999. Influence of 4 weeks' intervention by exercise and diet on low density lipoprotein subfractions in obese men with type 2 diabetes. Metabolism 48:641–644
Burr, M. L., Fehly, A. M., and Gilbert, J.F. 1989. Effect of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 2:757–761
Marcioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, X., Franzosi, M.G., Geraci, E., Levantesi, G., Maggioni, A.P., Mantini, L., Marfisi, R. M., Mastrogiuseppe, G., Mininni, N., Nicolosi, G. L., Santini, M., Schweiger, C., Tavazzi, L., Tognosi, G., Tucci, C., Valagussa, F. 2002. Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction: Time-Course Analysis of the Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 105:1897–1903
Bucher, H. C., Hengstler, P., Schindler, C., and Meier, G. 2003. N-3 polyunsaturated fatty acids in coronary heart disease: a metaanalysis of randomized controlled trials. Am J Med 112:298–304
GISSI-Prevenzione Investigators. 1999. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354:447–455
Hooper, L., Thompson, R. L., Harrison, R. A., Summerbell, C.D., Moore, H., Worthington, H.V., Durrington, P. N., Ness, A.R., Capps, N. E., Davey Smith, G., Riemersma, R. A., Ebrahim, S. B. J. 2006. Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: a systematic review. BMJ 332:752–760
Brown, G., Albers, J. J., Fisher, L.D., Schaefer, S. M., Lin, J.T., Kaplan, C., Zhao, X. Q., Bisson, B.D., Fitzpatrick, V.F., Dodge, H.T. 1990. Regression of coronary artery disease as a result of intensive lipid lowering therapy in men. New Engl J Med 323:1289–1298
The Long Term Intervention with Pravastatin in Ischemic Heart Disease (LIPID) Study Group. 1998. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels: the Long Term Intervention with Pravastatin in Ischemic Disease (LIPID) study. New Engl J Med 339:1349–1357
LaRosa, J. C., He, J., Vupputuri, S. 1999. Effect of Statins on Risk of Coronary Disease – a metaanalysis of randomized controlled trials. JAMA 282:2340–2346
Brown, G., Zhao, X. Q., Sacco, D. E., and Albers, J. J. 1993. Lipid-lowering and plaque regression: new insights into prevention of plaque disruption and clinical events in coronary artery disease. Circulation 87:1781–1791
Scandinavian Simvastatin Survival Study Group. 1994. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344:1383–1389
Heart Protection Study Collaborative Group 2002. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomized placebo-controlled trial. Lancet 360:7–22
Ridker, P. M., Cannon C.P., Morro, D., Rifai, N., Rose, L. M., McCabe, C. H., Pfeffer, M. A., Braunwald, E. for the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 PROVE IT-TIMI 22 Investigators. 2004. C-Reactive Protein Levels and Outcomes after Statin Therapy. New Engl J Med 352:20–28
Nissen, S. E., Tuzcu, M., Schoenhagen, P., Crowe, T., Sasiela, W. J., Tsai, J., Orazem, J., Magorien, R.D., O'Shauhnessy, C., Ganz, P., for the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) Investigators. 2005. Statin Therapy, LDL-Cholesterol, C-Reactive Protein, and Coronary Artery Disease. New Engl J Med 352:29–38
LaRosa, J. C., Grundy, S. M., Waters, D.D., Shear, C., Barter, P., Fruchart, J. C., Gotto, A. M., Greten, H., Kastelein, J. J.P., Sheperd, J., Wenger, N. K., for the Treating to New Targets (TNT) Investigators. 2005. Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease. New Engl J Med 352:1425–1435
Levine, G. N., Keaney, J.F., and Vita, J. A. 1995. Cholesterol reduction in cardiovascular disease – clinical benefits and possible mechanisms. New Engl J Med 332:512–521
O'Driscoll, G., Green, D., Taylor, R.R. 1997. Simvastatin and HMG-coenzyme. A reductase inhibitor improves endothelial function within 1 month. Circulation: 1126–1131
Bellosta, S., Ferri, N., Bernini, F., Paoletti, R., Corsini, A. 2000. Non-lipid- related effects of statins. Ann Med 32:164–176
Vaughan, C. J., Murphy, M.B., and Buckley, B.M. 1996. Statins do more than just lower cholesterol. Lancet 348:1079–1082
Rosenson, R. S. and Tangney, C.C. 1998. Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. J Am Med Assoc 279:1643–1650
Ridker, P. M., Rifai, N., Pfeffer, M. A., Sacks, F., Braunwald, E. 1999. Longterm effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation 100:230–235
Mitchell, L. B., Powell, J. L., Gillis, A. M., Kehl, V., Hallstrom, A.P., for the AVID Investigators. 2003. Are Lipid- Lowering Drugs Also Antiarrhythmic Drugs? An Analysis of the Antiarrhythmic Versus Implantable Defibrillators (AVID) Trial. J Am Coll Cardiol 42:81–87
Winkler, K., März, W., Baumstark, M.W., Berg, A. 2006. Besonderheiten im atherogenen Risikoprofil der KHK bei Frauen. In: Die koronare Herzkrankheit der Frau (Hrsg. Brachmann, J., Medau H. J.). Springer, ISBN 3798513112: 47–55
Bittner, V., Simon, J. A., Fong, J., Blumenthal, R. S., Newby, K., Stefanick, M.L. 2000. Correlates of high HDL cholesterol among woman with coronary heart disease. Am Heart J 139:288–296
Völler, H. et al. 1999. Auswirkung der stationären Rehabilitation auf kardiovaskuläre Risikofaktoren bei Patienten mit koronarer Herzerkrankung. Dtsch med Wschr 124:817–823
Gohlke, H., Jarmatz, H., Zaumseil, J., Bestehorn, K., Jansen, C., und Hasford, J. 2000. Einfluss eines optimierten Schnittstellenmanagements auf die Langzeiteffektivität der kardiologischen Rehabilitation. Dtsch med Wschr 125:1452–1456
Hoberg, E., Stockinger, J., Bestehorn, K., Wegscheider, K., für die HANSAStudiengruppe. 2002. Verbesserung des Risikofaktorenprofils durch drei halbtägige Auffrischungskurse innerhalb des ersten Jahres nach kardiologischer Rehabilitation – Ergebnisse der HANSA-Studie. Z Kardiol 91 (S5, abstract): 28
Küpper-Nybelen, J., Rothebacher, D., Hahmann, H., Wüsten, B., und Brenner, H. 2003. Veränderungen von Risikofaktoren nach stationärer Rehabilitation bei Patienten mit koronarer Herzkrankheit. Dtsch med Wschr 128:1525–1530
Stangl, V., Baumann, G., Stangl, K. 2002. Coronary atherogenic risk factors in women. Eur Heart J 23:1738–1752
Franco, V., Oparil, S., Carretero, O. A. 2004. Hypertensive Therapy: Part I. Circulation 109:2953–2958
Van den Hoogen, P. C., Feskens, E. J., Nagelkerke, N. J., Menotti, A., Nissinen, A., Kromhout, D. 2000. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven countries study research group. New Engl J Med 342:1–8
Lewington, S., Clarke, R., Qizilbash, N., Peto, R., Collins, R. 2002. Agespecific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360:1903–1913
Franco, V., Oparil, S., and Carretero, O. A. 2004. Hypertensive Therapy: Part II. Circulation 109:3081–3088
He, J., Whelton, P. K., Appel, L. J., Charleston, J., Klag, M.J. 2000. Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension 35:544–549
Sacks, F. M., Simons-Morton, V., Vollmer, W. M., Appell, L. J., Bray, G. A., Harsha, D., Obarzanek, E., Conlin, P.R., Miller, E. III, Simons-Morton, D. G., Karanja, N., Lin, P. H. 2001. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. New Engl J Med 344:3–10
Xin, X., He, J., Frontini, M.G., et al. 2001. Effects of alcohol reduction on blood pressure. Hypertension 38:1112–1117
Chobanian, A.V., Bakris, G. L., Black, H.R., Cushman, W. C., Green, L. A., Izzo, J.L. Jr., Jones, D.W., Materson, B. J., Oparil, S., Wright, J.T. jr., Rocella, E. J. 2003. Seventh report on the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: JNC 7 – Complete Report. Hypertension 42:1206–1252
European Society of Hypertension – European Society of Cardiology Guidelines Committee. 2003. European Society of Hypertension – European Society of Cardiology Guidelines for the Management of Arterial Hypertension. J Hypertens 21:1011–1053
Turnbull, F., for the Blood Pressure Lowering Treatment Trialists' Collaboration. 2003. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively designed overviews of randomized trials. Blood Pressure Lowering Treatment Trialists Collaboration. Lancet 355:1527–1535
Devine, E. C. and Reifschneider, E. 1995. A meta-analysis of the effects of psychoeducational care in adults with hypertension. Nursing Research 44:237–245
Vasan, R. S., Clarke, R., Leip, E.P. 2001. Assessment of frequency of progression to hypertension in nonhypertensive participants in the Framingham Heart Study: a cohort study. JAMA 358:1682–1686
Stetter, F., Kupper, S. 2003. Autogenic training: a meta-analysis of clinical outcome studies. Applied Psychophysiology and Biofeedback 27:45–98
Heart Outcomes Prevention Evaluation Study Investigators. 2000. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high risk patients. New Engl J Med 342:145–153
Kidney Disease Outcome Quality Initiative. 2002. National Kidney Foundation Guideline. KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39: S1–S246
UK Prospective Diabetes Study Group. 1998. UKPDS 39. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. Brit Med J 317:713–720
Therapieziele und Behandlungsstrategien beim Diabetes mellitus. 2005. AWMF-Leitlinien-Register 057/011K
Löwel, H., Stieber, J., König, W., Thorand, B., Hörmann, A., Gostomzyk, I. 1999. Das Diabetes-bedingte Herzinfarktrisiko in einer süddeutschen Bevölkerung: Ergebnisse der MONICA-Augsburg-Studien 1985–1994. Diabetes und Stoffwechsel 8:11–21
Rathmann, W., Haastert, B., Icks, A., Löwel, H., Meisinger, C., Holle, R. 2003. High prevalence of undiagnosed diabetes mellitus in Southern Germany: Targetpopulations for efficient screening. The KORA survey 2000. Diabetologica 46:182–189
Grundy, S. M., Benjamin, E. J., Burke, G. L., Chait, A., Eckel, R. H., Howard, B.V., Mitch, W., Smith, S. C., Sowres, J.R. 1999. Diabetes and Cardiovascular Disease. A Statement for healthcare Professionals from the American Heart Association. Circulation 100:1134–1146
Haffner, S. M., Lehto, S., Ronnemaa, T., Pyörala, K., and Laakso, M. 1998. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. New Engl J Med 339:229–234
Löwel, H., König, W., Engel, S., Hormann, A., Keil, U. 2000. The impact of diabetes mellitus on survival after myocardial infarction: can it be modified by drug treatment? Results of a population-based myocardial infarction register follow-up study. Diabetologica 43:218–226
Casiglia E, Zanette G, Mazza A, Donadon V, Donada C, Pizziol A, Tikhonoff V, Palatini P, Pessina AC. Cardiovascular mortality in non-insulin- dependent diabetes mellitus. A controlled study among 683 diabetics and 683 age- and sex-matched normal subjects. Eur J Epidemiol 16:677–684
Gaede, P., Vedel, P., Larsen, N., Jensen, G.V., Parving, H. H., Pedersen, O. 2003. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. New Engl J Med 348:383–393
Castaneda, C., Layne, J. E., Munoz-Orians, L., Gordon, P. L., Walsmith, J., Foldvari, M., Roubenoff, R., Tucker, K. L., Nelson, M.E. 2002. A randomized controlled trial of resistance exercise training to improve glycemic control in older adults with type 2 diabetes. Diabetes Care 25:2335–2341
Cuff, D. J., Meneilly, G. S., Martin, A., Ignaszewski, A., Tildesley, H.D., Fröhlich, J. J. 2003. Effective exercise modality to reduce insulin resistance in woman with type 2 diabetes. Diabetes Care 26:2977–2982
Knowler, W. C., Barrer, Connor, E., Fowler, S. E., Hamman, R.F., Lachin, J., Walker, E. A., Nathan, D.M. 2002. Reduction in the incidence of type 2 diabetes with lifestyle intervention or Metformin. New Engl J Med 346:393–403
Sigal, R. J., Kenny, G.P., Wasserman, D. H., Castaneda-Sceppa, C., White, R.D. 2006. Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabates Association. Diabetes Care 29:1433–1438
Heart Outcomes Prevention Evaluation Study Investigators. 2000. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 355:253–259
Mehler, P. S., Coll, J.R., Estarcio, R., Esler, A., Schrier, R.W., Hiatt, W.R. 2003. Intensive Blood Pressure Control Reduces the Risk of Cardiovascular Events in Patients with Peripheral Arterial Disease and Type 2 Diabetes. Circulation 207:753–756
UK Prospective Diabetes Study (UKPDS) Group. 1998. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317:703–713
Lüscher, T.F., Craeger, M. A., prepared with the assistance of Beckman, J. A. and Cosentino, F. 2005. Diabetes and Vascular Disease. Pathophysiology, Clinical Consequences, and Medical Therapy: Part II. Circulation 108:1655–1661
UK Prospective Diabetes Study (UKPDS) Group. 1998. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853
UK Prospective Diabetes Study (UKPDS) Group. 1998. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854–865
Grundy, S. M., Brewer, H. B., Cleeman, J. L., Smith, S. C., Lenfant, C., and for the Conference Participants. 2004. Definition of Metabolic Syndrome. Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation 109:433–438
Grundy, S. M., Hansen, B., Smith, S. C., Cleeman, J. I., Kahn, R. A., and for Conference Participants. 2004. Clinical Management of Metabolic Syndrome. Report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on Scientific Issues Related to Management. Circulation 109:551–556
LaMonte MJ, Blair SN, Church TS. 2005. Physical activity and diabetes prevention. J Appl Physiol 99:1205–1213
Wallberg-Henriksson, H., Rincon, J., Zierath, J.R. 1998. Exercise in the management of non-insulin-dependent diabetes mellitus. Sports medicine 25:25–35
Craeger, M. A., Lüscher, T.F., prepared with the assistance of Cosentino, F., Beckman, J. A. (Co-Chairmen). 2003. Diabetes and Vascular Disease. Pathophysiology, Clinical Consequences, and Medical Therapy: Part I. Circulation 108:1527–1532
Dormandy, J. A., Charbonnel, B., Eckland, D. J. A., Erdmann, E., Massi- Benedetti, M., Moules, I. K., Skene, A. M., Tan, M.H., Lefèbre, P. J., Murray, G.D., Standl, E., Wilcox, R. G., Wilhelmsen, L., Betteridge, J., Birkeland, K., Golay, A., Heine, R. J., Korányi, L., Laakso, M., Mokán, M., Norkus, A., Pirags, V., Podar, T., Scheen, A., Scherbaum, W., Schernthaner, G., Schmitz, O., Skrha, J., Smith, U., Taton, J., for the PROactive investigators. 2005. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomized controlled trial. Lancet 366:1279–1289
Hanefeld, M., Cagatay, M., Petrowitsch, T., Neuser, D., Petzinna, D., Rupp, M. 2004. Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven longterm studies. Eur Heart J 25:10–16
Festa, A., D'Agostino, R. Jr., Howard, G., Mykkänen, L., Tracy, R.P., Haffner, S.M. 2000. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102:42–47
Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. 2002. Circulation 106:3143–3421
Alberti KG, Zimmet P, Shaw J. for the IDF Epidemiology Task Force Consensus Group. 2005. The metabolic syndrome – a new worldwide definition. Lancet 366:1059–1062
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.R., Groop, L. 2001. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24:683–689
Toumilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Pastas M, Salminen V, Uusitipa M. 2001. Prevention of Type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343–1350
LaMonte MJ, Barlow CE, Jurca R, Kampert JB, Church TS, Blair SN. 2005. Cardiorespiratory fitness is inversely associated with the incidence of metabolic syndrome: a prospective study of men and women Circulation 112:505–512
Katzmarzyk PT, Church TS, Blair SN. 2004. Cardiorespiratory fitness attenuates the effects of the metabolic syndrome on all-cause and cardiovascular disease mortality in men. Arch Intern Med 164:1092–1097
Katzmarzyk, P.T., Church, T. S., Janssen, I., Ross, R., and Blair, S.N. 2005. Metabolic syndrome, obesity, and mortality: impact of cardiorespiratory fitness. Diabetes Care 28:391–397
Muredach, P., Reilly, M. B., Rader, D. J. 2003. The Metabolic Syndrome. More Than the Sum of Its Parts? Circulation 108:1546–1551
Kyrou I, Valsamakis G, Tsigos C. 2006. The endocannabinoid system as a target for the treatment of visceral obesity and metabolic syndrome. Annals of the New York Academy of Sciences 1083:270–305
Gelfand EV, Cannon CP. 2006. Rimonabant: a cannabinoid receptor type 1 blocker for management of multiple cardiometabolic risk factors. J Am Coll Cardiol 47:1919–1926
Mittag, O., Brusis, O. A., Held, K. 2001. Patientenschulung in der kardiologischen Rehabilitation. Praxis: Klinische Verhaltensmedizin und Rehabilitation 54:137–144
LaRosa, J. C. 2000. Poor Compliance: The Hidden Risk Factor. Current Atherosclerosis Reports 2:1–4
Clark, A. M., Hartling, L., Vandermeer, B., McAllister, F.A. 2005. Secondary prevention programs for patients with coronary artery disease. Annals of Internal Medicine 143:659–672
Sebregts, E.H.W. J., Falger, P.R. J, and Bär, F.W.H.M. 2000. Risk factor modification through nonpharmacological interventions in patients with coronary artery disease. J Psychosom Res 48:425–441
Dusseldorp, E., van Elderen, T., Maes, S., Meulman, J., and Kraaij, V. 1999. A meta-analysis of psychoeduational programs for coronary heart disease patients. Health Psychol 18:506–519
Balady, G. I., Ades, P. A., Comoss, P., Limacher, M., Pina, I. L., Southard, D.M.A., Bazzarre, T. 2000. Core components of cardiac rehabilitation/secondary prevention programs. A statement of health care professionals from the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation. Circulation 102:1069–1073
McDermott, M.M., Schmitt, B., and Wallner, E. 1997. Impact of medication non-adherence on coronary heart disease outcomes. A critical review. Arch Intern Med 157:1921–1929
Mullen, P.D., Mains, D. A., and Velez, R. 1992. A meta-analysis of controlled trials of cardiac patient education. Patient Educ Couns 19:143–162
Glazer, K. M., Emary, C.F., Frid, D. J., Banyasz, R. E. 2002. Psychological predictors of adherence and outcomes among patients in cardiac rehabilitation. J Cardiopulm Rehabil 22:40–46
Sung, J. C., Nichol, M.B., Venturini, E., Bailey, K. L., McCombs, J. S., Cody, M. 1998. Factors affecting patient compliance with antihyperlipidemic medications in an HMO population. Am J Manag Care 4:1421–1430
Reid, V., Mulcahy R. 1987. Nutrient intakes and dietary compliance in cardiac patients: 6 year follow-up. Hum Nutr Appl Nutr 41A:311–318
Lappalainen, R., Koikkalainen, M., Julkunen, J., Saarinen, T., Mykkanen, H. 1998. Association of sociodemographic factors with barriers reported by patients receiving nutrition counseling as part of cardiac rehabilitation. J Am Diet Assoc 98(9):1026–1029
Koikkalainen, M., Lappalainen, R., Mykkanen, H. 1996. Why cardiac patients do not follow the nutritionist's advice: Barriers in nutritional advice perceived in rehabilitation. Disability and Rehabilitation 8(12):619–623
Gohlke, H. 2004. Prävention durch Lebensstiländerung: Was ist gesichert? Herz 29:139–144
Nakanishi, N., Nakamura, K., Matsuo, Y., Suzuki, K., Tatara, K. 2000. Cigarette smoking and risk for impaired fasting glucose and type-2 diabetes in middle-aged Japanese men. Ann Int Med 133:183–191
He, J. 1999. Passive smoking and the risk of coronary heart disease – a meta-analysis of epidemiologic studies. New Engl J Med 340:920–926
Critchley, J. A., Capewell, S. 2004. Smoking cessation for the secondary prevention of coronary heart disease (Cochrane Review). The Cochrane Library 2. http://www.cochrane.org/reviews/
Daly, L. E., Mulcahy, R., Graham, I. M., Hickeay, N. 1983. Long term effect on mortality of stopping smoking after unstable angina and myocardial infarction. Brit Med J 287:324–326
Wilson K, Gibson N, Willan A, Cook D. 2000. Effect of smoking cessation on mortality after myocardial infarction. Arch Intern Med 160:939–944
Garratt, K. N., Grill, D. E., Lerman, A., Holmes, D.R., Hasdai, D. 1997. Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization. New Engl J Med 336:755–761
Hermanson, B., Omenn, G. S., Kronmal, R. A., Gersh, B. J. 1988. Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease. Results from the CASS registry. New Engl J Med 319:1365–1369
Lancaster, T. and Stead, L.F. 2004. Physician advise for smoking cessation (Cochrane Review). The Cochrane Library 4, http://www.cochrane.org/reviews/
Taylor, C.B. 1990. Smoking cessation after acute myocardial infarction: Effects of nurse managed intervention. Ann Intern Med 113:118–123
Lancaster, T. and Stead, L.F. 2005. Self-help interventions for smoking cessation (Cochrane Review). The Cochrane Library 4, http://www.cochrane.org/reviews/
Krumholz, H. M., Cohen, B. J., Tsevat, J., Pasternak, R. C., Weinstein, M.C. 1993. Cost-effectiveness of a smoking cessation program after myocardial infarction. J Am Coll Cardiol 22:1697–1702
Silagy, C., Mant, D., Fowler, G., Lancaster, T. 2000. Nicotine replacement therapy for smoking cessation. The Cochrane Library 4. http://www.cochrane.org/reviews/
Ranney, L., Melvin, C., Lux, L., McClain, E., Lohr, K. N. 2006. Systematic review: smoking cessation intervention strategies for adults and adults in special populations. Ann Int Med 145:845–856
Barth, J., Critchley, J., Bengel, J. Efficacy of psychosocial interventions for smoking cessation in patients with coronary heart disease: a systematic review and meta-analysis. Ann behavioral med 32:10–20
Hubbard, R., Lewis, S., Smith, C., Godfrey, C., Smeeth, L., Farrington, P., Britton, J. 2005. Use of nicotine replacement therapy and the risk of acute myocardial infarction, stroke, and death. Tobacco control 14:416–421
Etter, J.F., Stapleton, J. A. Nicotine replacement therapy for long-term smoking cessation: a meta-analysis. Tobacco control 15:280–285
Bupropion. 1994. U. S. drug monograph. http://www.mentalhealth.com/drug/p30-b04.html
Richmond, R., Zwar, N. 2003. Review of bupropion for smoking cessation. Drug and alcohol review 22:203–220
Rigotti, N. A., Thorndike, A. N., Regan, S., McKool, K., Pasternak, R. C., Chang, Y., Swartz, S., Torres-Finnerty, N., Emmons, K. M., Singer, D.E. 2006. Bupropion for smokers hospitalized with acute cardiovascular disease. Am J Med 119:1080–1087
de Logeril, M., Salen, P., Martin, J. L., Monjaud, I., Delaye, J., Mamelle, N. 1999. Mediterranean diet, traditional risk factors and the rate of cardiovascular complications after myocardial infarction. Circulation 99:779–785
Simopoulos, A.P. and Sidossis, L. S. 2000. What is so special about the traditional diet of Greece. The scientific evidence. World Rev Nutr Diet 87:43–55
de Logeril, M. and Salen, P. 2000. Modified mediterranean diet in the prevention of coronary heart disease and cancer. World Rev Nutr Diet 87:1–23
de Logeril, M., Salen, P., Defaye, P., Mabo, P., Paillard, F. 2002. Dietary prevention of sudden death. Eur Heart J 23:277–285
Kris-Etherton, P., Eckel, R. H., Howard, B.V., Jeor, S.T., Bazzarre, T. L., for the Nutrition Committee, Population Science Committee and Clinical Science Committee of the American Heart Association. 2001. Lyon Diet Heart Study – Benefits of a Mediteranean-Style, National Cholesterol Education Program/American Heart Association Step I Dietary Pattern on Cardiovascular Disease. Circulation 103:1823–1825
Morris, C.D., Carson, S. 2003. Clinical Guidelines: Routine Vitamin Supplementation To Prevent Cardiovascular Disease: A Summary of the Evidence for the U. S. Preventive Services Task Force. Ann Int Med 139:56–70
Gohlke, H. 2002. Ernährung und Gewicht. Z Kardiol 91 Suppl 2:II/12–24
Ajani, U. A., Gaziano, J. M., Lotufo, P. A., Liu, S., Hennekens, C. H., Buring, J. E., Manson, J. E. 2000. Alcohol consumption and risk of coronary heart disease by diabetes status. Circulation 102:500–505
de Logeril, M., Salen, P., Martin, J. L., Boucher, F., Paillard, F., de Leiris, J. 2002. Wine Drinking and Risks of Cardiovascular Complications After Recent Acute Myocardial Infarction. Circulation 106:1465–1469
Dhein, S., Michaelis, B., Mohr, F.W. 2005. Antiarrhythmic and electrophysiological effects of long-chain-3 polyunsaturated fatty acids. Naunyn- Schmiedeberg's Arch Pharmacol 371:202–211
Vlieg, P., Body, D., Burlinggame, B. 1988. Polyunsaturated fatty acid levels in the edible part of some common New Zealand fish and shellfish. J NZ Diet Assoc 42:15–19
Huang, Z., Willett, W. C., Manson, J. E., Manson, J. E., Rosner, B. Stampfer M.J., Speizer, F. E., Colditz, G. A. 1998. Body weight, weight change and risk for hypertension in woman. Ann Intern Med 128:81–88
Colditz, G. A., Willett, W. C., Rotnitzky, A., Manson, J. E. 1995. Weight gain as a risk factor for clinical diabetes mellitus in woman. Ann Int Med 122:481–486
Rexrode, K. M., Buring, J. E., Manson, J. E. 2001. Abdominal and total adiposity and risk of coronary heart disease in men. Int J Obes 25:1047–1056
Kenchaiah, S., Evans, J. C., Levy, D. 2002. Obesity and the risk of heart failure. New Engl J Med 347:305–313
McGill, H. C., McMahan, C. A., Herderick, E. E., Zieske, A.W., Malcom, G.T., Tracy, R. E., Strong, J.P. 2002. Obesity accelerates the progression of coronary atherosclerosis in young men. Circulation 105:2712–2718
Willet, W. C., Manson, J. E., Stampfer, M.J., Colditz, G. A., Rosner, B., Speizer, F. E., Hennekens, C.H. Weight, weight change, and coronary heart disease in woman. Risk within the ‘normal’ weight range. JAMA 273:461–465
Rowlands, A.V., Ingledew, D. K., and Eston, R. G. 2000. The effect of type of physical activity measure on the relationship between body fatness and habitual physical activity in children: a metaanalysis. Ann Hum Biol 27:479–497
Wei, M., Kampert, J. B., Barlow, C. E., Nichaman, M.Z., Gibbons, L.W., Paffenbarger, R. S., Blair, S.M. 1999. Relationship between low cardiorespiratory fitness in normal-weight, overweight, and obese men. JAMA 282:1547–1553
DiPietro, L. 1999. Physical activity in the prevention of obesity: current evidence and research issues. Med Sci Sports Exerc 31: S542–S546
Yanovski, S. Z. and Yanovski, J. A. 2002. Obesity. N Engl J Med 346:591–602
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults – The Evidence report. National Institutes of Health. Obesity research 6, Suppl 2: 51S–209S
Miller, W. C., Koceja, D. M., and Hamilton, E. J. 1997. A metaanalysis of the past 25 years of weight loss research using diet, exercise or diet with exercise intervention. Int J Obes 21:941–947
Jakicic, J. M., Winters, C., Lang, W., and Wing, R.R. 1999. Effects of intermittent exercise and use of home exercise equipment on adherence, weight loss and fitness in overweight women. 282:1554–1560
Ross, R., Janssen, I. 2001. Physical activity, total and regional obesity; dose-response considerations. Medicine and Science in Sports and Exercise 33 (Suppl 6):S521–S527
Curioni, C. C., Lourenco, P.M. 2005. Long-term weight loss after diet and exercise: a systematic review. J Obes 29:1168–1174
Foster GD, Wyatt HR, Hill JO, McGuckin BG, Brill C, Mohammed BS, Szapary PO, Rader DJ, Edman, JS, Klein S. 2003. A randomized trial of a low – carbohydrate diet for obesity. New Engl J Med 348:2082–2090
Dansinger ML, Gleason JA, Griffith JL, Selker HP, Schaefer EJ. 2005. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA 293:43–53
Ziegelstein, R. C. 2001. Depression in patients recovering from a myocardial infarction. JAMA 286:1621–1627
Rugulies, R. 2002. Depression as a predictor for coronary heart disease. A review and meta-analysis. Am J Prev Med 23:51–61
Wulsin, L.R., Singal, B.M. 2003. Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosom Med 65:201–210
Barth, J., Schumacher, M., and Herrmann- Lingen, C. 2004. Depression as a risk factor for mortality in patients with coronary heart disease: a metaanalysis. Psychosom Med 66:802–813
van Melle, J.P., de Jonge, P., Spijkerman, T. A., Tijssen, J. G., Ormel, J., van Veldhuisen, D. J., van den Brink, R. H., van den Berg, M.P. 2004. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis. Psychosom Med 66:814–822
Kuper, H., Marmot, M., Hemingway, H. 2002. Systematic review of prospective cohort studies of psychosocial factors in the aetiology and prognosis of coronary heart disease. Semin Vasc Med 2:1271–1278
Musselman, D. L., Evans, D. L., Nemeroff, C. B. 1998. The relationship of depression to cardiovascular disease: epidemiology, biology and treatment. Arch Gen Psychiatry 55:580–592
Rozanski, A., Blumenthal, J. A., Kaplan, J. 1999. Impact of Psychological Factors on the Pathogenesis of Cardiovascular Disease and Implications for Therapy. Circulation 99:2192–2217
Scheier, M.F., Bridges, M.W. 1995. Person variables and health: personality predispositions and acute psychological states as shared determinants for disease. Psychosom Med 57:255–266
Hemingway, H., Malik, M., Marmot, M. 2001. Social and psychological influences on sudden cardiac death, ventricular arrhythmia and cardiac autonomic function. Eur Heart J 22:1082–1101
Jiang, W., Kuchibhatla, M., Cuffe, M.S., Christopher, E. J., Alexander, J.D., Clary, G. L., Blazing, M. A., Gaulden, L. H., Califf, R. M., Krishnan, R.R., and O'Connor, C.M. 2004. Prognostic Value of Anxiety and Depression in Patients With Chronic Heart Failure. Circulation 110:3452–3456
Zellweger, M. J., Osterwalder, R. H., Langewitz, W., Pfisterer, M.E. 2004. Coronary artery disease and depression. Eur Heart J 25:3–9
Frasure-Smith, N., Lesperance, F., and Talajik, M. 1993. Depression following myocardial infarction. Impact on 6-month survival. JAMA 270:1819–1825
Frasure-Smith, N., Lesperance, F., and Talajik, M. 1995. Depression and 18-month prognosis after myocardial infarction. Circulation 91:999–1005
Ladwig, K. H., Kieser, M., König, J., Breithardt, G., Borggreffe, M. 1991. Affective disorders and survival after acute myocardial infarction. Results from the post-infaction late potential study. Eur Heart J 12:959–964
Abramson, J., Berger, A., Krumholz, H. M., and Vaccarino, V. 2001. Depression and risk of heart failure among older persons with isolated systolic hypertension. Arch Intern Med 161:1725–1730
Jiang, W., Alexander, J.D., Christopher, E. J., Kuchibhatla, M., Gaulden, L. H., Cuffe, M.S., Blazing, M. A., Davenport, C., Califf, R. M., Krishnan, R.R., O'Connor, C.M. 2001. Relationship of depression to increased risk of mortality and rehospitalization. Arch Intern Med 161:1849–1856
Bunker, S. J., Colquhoun, D. M., Esler, M.D., Hickie, I. B., Hunt, D., Jelinek, V. M., Oldenburg, B.F., Peach, H. G., Ruth, D., Tennant, C. C., and Tonkin, A.M. 2003. “Stress” and coronary heart disease: psychological risk factors. National Heart Foundation of Australia position statement update. MJA 178:272–276
Kubzansky, L.D., Kawachi, I. 2000. Going to the heart of the matter. Do negative emotions cause coronary heart disease? J Psychosom Res 48:323–337
Kawachi, I., Colditz, G. A., Ascherio, A., Rimm, E. B., Giovannucci, E., Stampfer, M. J., Willett, W. C. 1994. Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation 89:1992–1997
Albert, C. M., Chae, C.U., Rexrode, K. M., Manson, J. E., Kawachi, I. 2005. Phobic anxiety and risk of coronary heart disease and sudden cardiac death among women. Circulation 111:480–487
Sharkey, S.W., Lesser, J.R., Zenovich, A. G., Maron, M.S., Lindberg, J., Longe, T.F., and Maron, B. J. 2005. Acute and reversible cardiomyopathy provoked by stress in women from the United States. Circulation 111:472–479
Wittstein, I. S., Thiemann, D.R., Lima, J. A., Baughman, K. L., Schulman, S.P., Gerstenblith, G., Wu, K. C., Rade, J. J., Bivalacqua, T. J., Champion, H. C. 2005. Neurohumoral features of myocardial stunning due to sudden emotional stress. New Engl J Med 352:539–548
Orth-Gomer, K., Wamala, S.P., Horsten, M., Schenck-Gustafsson, K., Schneiderman, N., Mittleman, M.A. 2000. Marital stress worsens prognosis in woman with coronary heart disease: The Stockholm Female Coronary Risk Study. JAMA 284:3008–3014
Schnall, P. L., Landsbergis, P. A., Baker, D. 1994. Job strain and cardiovascular disease. Annu Rev Public Health 15:381–411
Myrtek, M. 2001. Meta-analyses of prospective studies on coronary heart disease, type A personality, and hostility. Int J Cardiol 79:245–251
Denollet, J., Brutsaert, D. L. 1998. Personality, disease severity, and the risk of long-term cardiac events in patients with a decreased ejection fraction after myocardial infarction. Circulation 97:167–173
Denollet, J., Vaes, J., Brutsaert, D. L. 2005. Inadequate response to treatment in coronary heart disease: adverse effects of type D personality and younger age on 5-year prognosis and quality of life. Circulation 102:630–635
Pedersen, S. S., Lemos, P. A., van Vooren, P.R., Liu, T. K., Daemen, J., Erdman, R. A., Smits, P. C., Serruys, P.W., van Domburg, R.T. 2004. Type D personality predicts death or myocardial infarction after bare metal stent or sirolimus-eluting stent implantation: a Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry substudy. J Am Coll Cardiol 44:997–1001
Brezinka, V., Kittel, F. 1995. Psychosocial factors of coronary heart disease in women: a review. Social Science and Medicine 42:1351–1365
Rees, K., Bennett, P., West, R., Davey Smith, G., and Ebrahim, S. 2004. Psychological interventions for coronary heart disease (Cochrane Review). The Cochrane Library 2. http://www.cochrane.org/reviews/
Linden, W., Stossel, C., Maurice, J. 1996. Psychosocial interventions for patients with coronary artery disease: a meta-analysis. Arch Intern Med 156:745–752
Sheps, D. S., Freedland, K. E., Golden, R. N., McMahon, R.P. 2003. ENRICHED and SADHART: implications for future biobehavioral efforts. Psychosom Med 65:1–2
Berkman, L.F., Blumenthal, J., Burg, M., Carney, R. M., Catellier, D., Cowan, M.J., Czajkowski, S. M., DeBusk, R., Hosking, J., Jaffe, A., Kaufmann, P. G., Michell, P., Norman, J., Powell, L. H., Raczynski, J. M., Schneiderman, N. for the ENRICHED investigators. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHED) Randomized Trial. JAMA 289:3106–3116
Frasure-Smith, N., Lespérance, F., Prince, R. H., Verrier, P., Garber, R. A., Juneau, M., Wolfson, C., Bourassa, M.G. 1997. Randomized trial of home-based psychosocial nursing intervention for patients recovering from myocardial infarction. Lancet 350:473–479
Schneiderman, N., Saab, P. G., Catellier, D. J., Powell, L. H., DeBusk, R.F., Williams, R. B., Carney, R. M., Raczynski, J. M., Cowan, M.J., Berkman, L.F., Kaufmann, P. G., for the ENRICHED Investigators. 2004. Psychosozial treatment within sex by ethnicity subgroups in the Enhancing Recovery in Coronary Heart Disease clinical trial. Psychosom med 66:475–483
Januzzi, J. L. Jr., Stern, T. A., Pasternak, R. C., DeSanctis, R.W. 2000. The influence of anxiety and depression on outcomes of patients with coronary artery disease. Arch Intern Med 160:1913–1921
Milani, R.V. and Lavie, C. J. 2005. Prevalence and effects of cardiac rehabilitation on depression in the elderly with coronary heart disease. Am J Cardiol 81:1233–1236
Lavie, C. J., Milani, R.V., Cassidy, M.M., Gilliland, Y. E. 1999. Effects of cardiac rehabilitation and exercise training programs in women with depression. Am J Cardiol 83:1480–1483
Turner, S. C., Bethell, H. J., Evans, J. A., Goddard, J.R., Mullee, M.A. 2002. Patients characteristics and outcomes of cardiac rehabilitation. J Cardiopulm Rehabil 22:253–260
Blanchard, C. M., Rodgers, W. M., Courneya, K. S., Dau, B., Black, B. 2002. Self-efficacy and mood in cardiac rehabilitation: should gender be considered? Behav Med 27:149–160
Gill, D., Hatcher, S. 2004. Antidepressants for depression in medical illness. Cochrane Library 1. http://www.cochrane.org/reviews/
Sauer, H.W., Berlin, J. A., Kimmel, S. E. 2003. Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction. Circulation 108: 32–36
Myrtek, M., Kaiser, A., Rauch, B., Jansen, G. 2001. Factors associated with work resumption: A 5 year follow- up with cardiac patients. Int J Cardiol 59:291–297
Mittag, O., Kolenda, K.D., Nordman, K. J., Bernien, J., Maurischat, C. Return to work after myocardial infarction/coronary artery bypass grafting: patients' and physicians' initial viewpoint and outcome 12 months later. Social Science and Medicine 52:1441-1450
Verband Deutscher Rentenversicherungsträger. 2003. Sozialmedizinische Begutachtung für die gesetzliche Rentenversicherung. 6. Auflage
Fletcher, G.F., Balady, G. J. 2001. AHA Scientific Statement: Exercise Standards for Testing and Training. Circulation 104:1694–1740
Fröhlicher, E. S., Kee, L. L., Newton, K.., Lindskog, B., Livingston, M. 1994. Return to work, sexual activity, and other activities after acute myocardial infarction. Heart and Lung 23:423–435
Petrie, K., Weinman, J., Sharpe, N., Buckley, J. 1996. Role of patient's view of their illness in predicting return to work and functioning after myocardial infarction: longitudinal study. Brit Med J 312:1191–1194
Perski, A., Osuchowski, K., Andersson, L., Sanden, A., Feleke, E., Anderson, G. 1999. Intensive rehabilitation of emotionally distressed patients after coronary bypass grafting. J Internal Medicine 246:253–263
Thomas, S. A., Friedmann, E., Wimbush, F., Schron, E. 1997. Psychological factors and survival in the cardiac arrhythmia suppression trial (CAST): a re-examination. Am J Crit Care 6:116–126
Budde, H. G. und Keck, M. 2001. Prädiktoren der beruflichen Wiedereingliederung nach stationärer kardiologischer Rehabilitation im Rahmen der Arbeiterrentenversicherung. Predictors of return to work after inpatient cardiac rehabilitation under workers compensation plan. Die Rehabilitation 40:208–216
Frasure-Smith, N., Lesperance, F., Gravel, G., Masson, A., Juneau, M., Talajic. M., Bourassa, M.G. 2000. Social support, depression, and mortality during the first year after myocardial infarction. Circulation 101:1919–1924
Welin, C., Lappas, G., Wilhelmsen, L. 2000. Independent importance of psychosocial factors for prognosis after myocardial infarction. J Internal Medicine 247:629–639
Barefoot, J., Brummett, B., Clapp- Channing, N. E., Siegler, I. C., Vitaliano, P.P., Williams, R. B., Mark, D. B. 2000. Moderators of the effect of social support on depressive symptomes in cardiac patients. Am J Cardiol 86:438–442
Müller-Farnow, W. 1994. Medizinische Rehabilitation. Die Berliner KHK-Studie. Juventa: 129–158
Sellier, P., Varaillac, P., Chatellier, G., D'Agrosa-Boiteux, M.C., Douard, H., Dubois, C., Goepfert, P. C., Monpère, C., Pierre, A. S. 2003. Factors influencing return to work at one year after coronary bypass graft surgery: results of the PERISCOP study. Eur J Cardiovasc Prev Rehab 10:469–475
Boudrez, H. and De Backer, G. 2000. Recent findings on return to work after an acute myocardial infarction or coronary artery bypass grafting. Acta Cardiol 55:341–349
Mark, D. B., Lam, L. C., Lee, K. L., Clapp-Channing, N. E., Williams, R. B., Pryor, D. B., Califf, R. M., Hlatky, M.A. 1992. Identification of patients with coronary disease at high risk for loss of employment. A prospective validation study. Circulation 86:1485–1494
Noyez, L., Onundu, J.W., Janssen, D.P., Stotnicki, S. H., Lacquet, L. K. 1999. Myocardial revascularization in patients < or = 45 years old: evaluation of cardial and functional capacity, and return to work. Cardiovasc Surg 7:128–133
Erbstößer, S., Nellessen, G., Schuntermann, M. 2003. FCE-Studie: FCE-Systeme zur Beurteilung der arbeitsbezogenen Leistungsfähigkeit – Bestandsaufnahme und Experteneinschätzung. Abschlussbericht (Hrsg. Verband Deutscher Rentenversicherungsträger). DRV-Schriften, Band 44.
Bundesarbeitsgemeinschaft für Rehabilitation (BAR Frankfurt). 2006. ICFPraxisleitfaden. Trägerübergreifender Leitfaden für die praktische Anwendung der ICF (Internationale Klassifikation der Funktionstüchtigkeit, Behinderung und Gesundheit) beim Zugang zur Rehabilitation.
Begutachtungs-Leitlinien zur Kraftfahrereignung. 2000. Berichte der Bundesanstalt für Straßenwesen, BASt-Bericht M115
Covinsky, K. E., Chren, M.M., Harper, D., Way, L. E., Rosenthal, G. E. 2000. Differences in patient-reported processes and outcomes between men and women. J Gen Intern Med 15:169–174
Duits, A. A., Boeke, S., Taams, M.A., Passchier, J., Erdman, R. A. 1997. Prediction of quality of live after coronary bypass graft surgery: a review and evaluation of multiple, recent studies. Psychosom Med 59:257–268
Geissler, H. J., Hölzl, P., Marohl, S., Kuhn-Régnier, F., Mehlhorn, U., Südkamp, M., de Vivie, E.R. 2000. Risk stratification in heart surgery: comparison of six score systems. Eur J Cardiothorac Surg 17:400–406
Huysmans, H. A. and Van Ark, E. 1989. Predictors of perioperative mortality, morbidity and late quality of life in coronary bypass surgery. Eur Heart J (Suppl H) 10:10–12
Herlitz, J., Wiklund, I., Caidahl, K., Karlson, B.W., Sjöland, H., Hartford, M., Haglid, M., Karlsson, T. 1999. Determinants of impaired quality of life five years after coronary artery bypass surgery. Heart: 342–346
Jenkins, C.D., Stanton, B. A., and Jono, R.T. 1994. Quantifying and predicting recovery after heart surgery. Psychosom Med 56:203–212
Andrew, M. J., Baker, R. A., Kneebone, A. C., Knight, J.L. 2000. Mood state as a predictor of neuropsychological deficits following cardiac surgery. J Psychosom Res 48:537–546
Werling, C. und Saggau, W. 2001. Postthorakotomiesyndrom und Wundheilungsstörung – Probleme in der Rehabilitation aus Sicht des Chirurgen. Der schwerkranke und multimorbide Herzpatient – eine Herausforderung für die kardiologische Rehabilitation (Hrsg. Rauch, B., Held, K., Steinkopff, Darmstadt; ISBN 3-7985-1323-6):108–113
Alamassi, G. H., Sommers, T., Kneebone, A. C., Knight, J.L. 2001. Stroke in cardiac surgical patients: determinants and outcome. Ann Thorac Surg 68:391–397
Borger, M. A., Rao, V., Weisel, R.D. 1998. Deep sternal wound infection: risk factors and outcomes. Ann Thorac Surg 65:1050–1060
Karlsson, I., Berglin, E., Pettersson, G., Larsson, P. A. 1999. Predictors of chest pain after coronary artery bypass grafting. Scand Cardiovasc J 33:289–294
Newman, M.F., Kirchner, J. L., Phillips-Bute, B. 2001. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. New Engl J Med 344:395–402
Zacharias, A. and Habib, R. H. 1996. Factors predisposing to median sternotomy complications. Deep vs superficial infection. Chest 110:1173–1178
Naslafkih, A., Francois, S., Fix, J. M., Khoury, A. 2006. Aortic valve replacement and long-term prognosis. J Insur Med 38:126–135
Beiser, G.D., Epstein, S. E., Stampfer, M., Robinson, B., Braunwald, E. 1968. Studies on Digitalis XVIII: Effects of Ouabain on the Hemodynamic Response to Exercise in Patients with Mitral Stenosis in Normal Sinus Rhythm. N Engl J Med 27S:131–142
Chattelier, S., Chauvand, J., Fabiani, N., Carpentier, A. 2001. Very Long Term Results (More than 20 Years) of Valve Repair with Carpentier's Techniques in Nonrheumatic Mitral Valve Insufficiency. Circulation 104 Suppl I:8–11
Cowie, M.R., Mosterd, A., Wood, D. A., Deckers, J.W., Poole-Wilson, P. A., Sutton, G. C., Grobbee, D. E. 1997. The epidemiology of heart failure. Eur Heart J 18:208–225
Davies, M., Hobbs, F., Davis, R., Kenkre, J., Roalfe, A. K., Hare, R., Wosornu, D., Lancashire, R. J. 2001. Prevalence of left ventricular systolic dysfunction and heart failure in the Echographic Heart of England Screening Study: a population based study. Lancet 2001:439–444
Fischer, M., Baessler, A., Holmer, S.R., Muscholl, M., Bröckel, U., Luchner, A., Hense, H.-W., Döring, A., Riegger, G., Schunkert, H. 2003. Epidemiologie der linksventrikulären systolischen Dysfunktion in der Allgemeinbevölkerung Deutschlands. Ergebnisse echokardiographischer Untersuchungen einer großen Bevölkerungsstichprobe. Z Kardiol 92:294–302
Lloyd-Jones, D. M., Larson, M.G., Leip, E.P., Beiser, A., D'Agostino, R. B., Kannel, W. B., Murabito, J. M., Vasan, R. S., Benjamin, E. J., Levy, D. 2002. Lifetime Risk for Developing Congestive Heart Failure. The Framingham Heart Study. Circulation 106:3068–3072
Fox, K.F., Cowie, M.R., Wood, D. A., Coats, A. J., Gibbs, J. S., Underwoood, S.R., Turner, R. M., Poole-Wilson, P. A., Davies, S.W., Sutton, G. C. 2001. Coronary artery disease as the cause of heart failure in the population. Eur Heart J 22:228–236
McMurray, J. J., Stewart, S. 2000. Epidemiology, aetiology, and prognosis of heart failure. Heart 83:596–602
Erbs, S., Linke, A., Gielen, S., Fiehn, E., Walther, C., Yu, J., Adams, V., Schuler, G., and Hambrecht, R. 2003. Exercise training in patients with severe chronic heart failure: impact on left ventricular performance and cardiac size. A retrospective analysis of the Leipzig Heart Failure Training Trial. Eur J Cardiovasc Prev Rehab 10:336–344
Horne, R., Weinmann, J. 1999. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 47:555–567
Michaelsen, A., König, G., Thimme, W. 1998. Preventable causative factors leading to hospital admission with decompensated heart failure. Heart 80:437–441
Senni, M., Tribouilloy, C. M., Rodeheffer, R. J., Jacobsen, S. J., Evans, J. M., Bailey, K.R., Redfield, M.M. 1999. Congestive Heart failure in the Community; Trends in Incidence and Survival in a 10-Year Period. Arch Intern Med 159:29–34
Wagdi, P., Vuilliomenet, A., Kaufmann, U., Richter, M., Bertel, O. 1993. Ungenügende Behandlungsdisziplin, Patienteninformation und Medikamentenverschreibung als Ursachen für die Notfallhospitalisation bei chronisch herzinsuffizienten Patienten. Schweiz med Wschr 123:108–112
Haldeman, G. A., Croft, J. B., Giles, W. H., Rashidee, A. 1999. Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995. Am Heart J 137:352–360
Pina, I. L., Apstein, C. S., Balady, G. I., Belardinelli R., Chaitman, B.R., Duscha, B.D., Fletcher, B. J., Fleg, J. L., Myers, J. N., Sullivan, M.J. 2003. Exercise and heart failure: A statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. Circulation 107:1210–1225
Corra, U., Mezzani, A., Gianuzzi, P., Tavazzi, L. 2003. Chronic heart failure- related myopathy and exercise training: a developing therapy for heart failure symptoms. Curr Probl Cardiol 28:521–547
Tasc Working Group. 2002. Management of Peripheral Arterial Disease, TransAtlantic Inter-Society Consensus. International Angiology 2000, 19 (Suppl 1):1–309
Diehm, C., Schuster, A., Allenberg, J.R., Darius, H., Haberls, R., Lange, S., Pittrow, D., von Stritzky, B., Tepohl, G., Trampisch, H. J. 2004. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross sectional study. Atherosklerosis 172:95–105
Murabito, J. M., Evans, J. C., Nieto, K., Larson, M.G., Levy, D., Wilson, P.W. 2002. Prevalence and Clinical Correlates of Peripheral Arterial Disease in the Framingham Offspring Study. Am Heart J 143:961–965
Deutsche Gesellschaft für Angiologie. 2001. Leitlinien zur Diagnostik und Therapie der arteriellen Verschlusskrankheit der Becken-Beinarterien. VASA 30 Suppl 57:5–19
McDemott, M.M., Guvalnik, J. M., Greenland, P. 2003. Statin Use and Leg Functioning in Patients With and Without Lower Extremity Peripheral Disease. Circulation 107:757–761
Gardener, A.W., Katzel, L. I., Sorkin, J.D., Goldberg, A.P. 2002. Effects of Long-Term Exercise Rehabilitation on Claudication Distance in Patients with Peripheral Arterial Disease. A Randomized Controlled Study. J Cardiopulm Rehabil 22:192–198
Leng, G. C., Fowler, B., Ernst, E. 2004. Exercise for intermittent claudication (Cochrane Review). The Cochrane Library 4. http://www.cochrane.org/reviews/
Stewart, K. J., Hiatt, W.R., Regensteiner, J. G., Hirsch, A.T. 2006. Exercise training for claudication. N Engl J Med 347:1941–1951
Degischer, S., Labs, K. H., Hochstrasser, J., Aschwanden, M., Tschoepl, M., Jaeger, K.A. 2002. Physical training for intermittent claudication: a comparison of structured rehabilitation versus home-based training. Vasc Med 7:109–115
Roller, R. E., Dorr, A., Ulrich, S., Pilger, E. 2002. Effect of Aspirin Treatment in Patients with Peripheral Arterial Disease Monitored with the Platelet Function Analyzer PFA-100. Blood Coagulation Fibrinolysis 13:277–281
CAPRIE Steering Committee. 1996. A Randomized, Blinded Trial of Clopidogrel versus Aspirin in Patients at Risk of Ischemic Events (CAPRIE). Lancet 348:1329–1339
Pauwels, R. A., Rabe, K.F. 2004. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 364:613–620
Fabbri, L., Pauwels, R. A., Hurd, S. S. 2004. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary updated 2003. COPD 1:105–141
Worth, H., Buhl, R., Cegla, U., Criee, C.P., Gillisen, A., Kardos, P., Köhler, D., Magnussen, H., Meister, R., Nowak, D., Petro, W., Rabe, K.F., Schultze-Werninghaus, G., Sitter, H., Teschler, H., Welte, T., Wettengel, R. 2002. Leitlinie der Deutschen Atemwegsliga und der Deutschen Gesellschaft für Pneumologie zur Diagnostik und Therapie von Patienten mit chronisch obstruktiver Bronchitis und Lungenemphysem (COPD). Pneumologie 56:704–738
Benesch, L., Bjarnason-Wehrens, B., Cordes, C., Franz, I.-W., Grunze, M., Gysan, D., Hoberg, E., Hoffmann, K., Karoff, M., Klein, G., Schröder, K., Theisen, F., Tönnesmann, U., Völler, H., Volger, E., Willemsen, D., Wirth, A., Witt, T. 2004. Chronisch-obstruktive Bronchitis und Emphysem (COPD): Umsetzungsempfehlung von Leitlinien. Herzmedizin 21:42–104
Celli, B.R. 1995. Pulmonary rehabilitation in patients with COPD. Am J Respir Critical Care Med 152:861–864
Kjoller, E., Kober, L., Iversen, K., Torp-Pedersen, C., on behalf of the Trace Study Group. 2004. Importance of chronic obstructive pulmonary disease for prognosis and diagnosis of congestive heart failure in patients with acute myocardial infarction. International Angiology 19 Suppl 1:1–309
Troosters, T., Gosselink, R., Decramer, M. 2004. Chronic obstructive pulmonary disease and chronic heart failure: two muscle diseases? J Cardiopulm Rehabil 24:137–145
Pereira, M.C., Isayama, R. N., Seabra, J. C., Campos, G. E., Paschoal, I. A. 2004. Distribution and morphometry of skeletal muscle fibers in patients with chronic obstructive pulmonary disease and chronic hypoxemia. Muscle & Nerve 30:796–798
Antonucci, R., Berton, E., Huertas, A., Laveneziana, P., Palange, P. 2003. Exercise physiology in COPD. Monaldi Archives for Chest Disease 59:134–139
Lacasse, Y., Brosseau, L., Milne, S., Martin, S., Wong, S., Guyatt, G. H., Goldstein, R. S., White, J. 2004. Pulmonary rehabilitation for chronic obstructive pulmonary disease (Cochrane Review). The Cochrane Library 4. http://www.cochrane.org/reviews/
Wijkstra, P. J., Ten Vergert, E. M., van Altena, R., Otten, V., Kraan, J., Postma, D. S., Koeter, G.H. 1995. Long term benefits of rehabilitation at home on quality of life and exercise tolerance in patients with chronic obstructive pulmonary disease. Thorax 50:824–828
Berry, M.J., Rejeski, W. J., Adair, N. E., and Zaccaro, D. 1999. Exercise rehabilitation and chronic obstructive pulmonary disease stage. Am J Respir Crit Care Med 160:1248–1253
Foglio, K., Bianchi, L., Bruletti, G., Battista, L., Pagani, M., Ambrosino, N. 1999. Long-term effectiveness of pulmonary rehabilitation in patients with chronic airway obstruction. Eur Respir J 13:125–132
Weiner, P., McConnell, A. 2005. Respiratory muscle training in chronic obstructive pulmonary disease: inspiratory, expiratory, or both? Current Opinion in Pulmonary Medicine 11:140–144
Anthonisen, N.R., Connett, J. E., Kiley, J.P., Altose, M.D., Bailey, W. C., Buist, A. S., Conway, W.A. Jr., Enright, P. L., Kanner, R. E., O'Hara, P. 1994. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: The Lung Health Study. JAMA 272:1497–1505
Wise, R. A., Kanner, R. E., Lindgren, P., Connett, J. E., Altose, M.D., Enright, P. L., Tashkin, D.P. 2003. The effect of smoking intervention and an inhaled bronchodilator on airways reactivity in COPD: the Lung Health Study. Chest 124:449–458
Monninkhof, E. M., van der Valk, P.D. L.P. M., van der Palen, J., van Herwaarden, C. L. A., Partridge, M.R., Walters, E. H., and Zielhuis, G. A. 2004. Self-management education for chronic obstructive pulmonary disease (Cochrane Review). The Cochrane Library 4. http://www.cochrane.org/reviews/
Pauwels, R. A., Lofdahl, O. G., Laitinen, L. A., Schouten, J.P., Postma, D. S., Pride, N. B., Ohlsson, S.V. 1999. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. N Engl J Med 340:1948–1953
Burge, P. S., Calverley, P. M., Jones, P.W., Spencer, S., Anderson, J. A., Maslen, T. K. 2000. Randomised, double blind, placebo controlled study of fluticasone proprionate in patients with moderate to severe chronic obstructive pulmonary disease. The ISOLDE trial. BMJ 320:1297–1303
Tarpy, S.P., Celli, B.R. 1995. Longterm oxygen therapy. New Engl J Med 333:710–714
Young, T., Palta, M., Dempsey, J., Skatrud, J., Weber, S., Badr, S. 1993. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:1230–1235
Shahar, E., Whitney, C.W., Redline, S., Lee, E.T., Newman, A. B., Javier, N.F., O'Connor, G.T., Boland, L. L., Schwartz, J. E., Samet, J.M. 2001. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163:19–25
Marin, J. M., Carrizo, S. J., Vicente, E., Agusti, A. G. 2005. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365:1046–1053
Sin, D.D., Fitzgerald, F., Parker, J.D., Newton, G., Floras, J. S., Bradley, T.D. 1999. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 160:1101–1106
Fischer, J., Mayer, G., Peter, J. H., Riemann, D., Sitter, H. 2002. Nicht-erholsamer Schlaf. Leitlinie „S2“ der Deutschen Gesellschaft für Schlafforschung und Schlafmedizin.
Becker, H.F., Jerrentrup, A., Ploch, T., Grote, L., Penzel, T., Sullivan, C. E., Peter, J.H. 2003. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 107:68–73
Teschler, H., Döhring, J., Wang, Y. M., Berthon-Jones, M. 2005. Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med 164:614–619
Thompson, D.R., Bowman, G. S. 1998. Evidence of the effectiveness of cardiac rehabilitation. Intensive Crit Care Nurs 14:38–48
Stahle, A., Nordlander R, Ryden L, Mattsson, E. 1999. Effects of organized aerobic group training in elderly patients discharged after an acute coronary syndrome. A randomized controlled study. Scand J Soc Med 31:101–107
Stahle, A., Nordlander R, and Bergfeldt, L. 1999. Aerobic group training improves exercise capacity and heart rate variability in elderly patients after a acute coronary event. A randomized controlled study. Eur Heart J 20:1638–1646
Gayda, M., Juneau, M., Levesque, S., Guertin, M.C., Nigam, A. 2006. Effect of long-term and ongoing cardiac rehabilitation in elderly patients with coronary heart disease. Am J Geriatric Cardiol 15:345–351
Giallauria, F., Lucci, R., De Lorenzo, A., D'Agostino, M., Del Forno, D., Vigorito, C. 2006. Favourable effects of exercise training on N-terminal pro-brain natriuretic peptide plasma levels in elderly patients after acute myocardial infarction. Age and ageing 35:601–607
Singh, S. 2005. Cardiac rehabilitation improves quality of life and walking tolerance in elderly patients with heart failure. Australian J Physiother 51:191
Ferrara, N., Corbi, G., Bosimini, E., Cobelli, F., Furgi, G., Giannuzzi, P., Giordano, A., Pedretti, R., Scrutinio, D., Rengo, F. 2006. Cardiac rehabilitation in the elderly: patient selection and outcomes. Am J Geriatric Cardiol 15:22–27
Austin, J., Williams, R., Ross, L., Moseley, L., Hutchison, S. 2005. Randomized controlled trial of cardial rehabilitation in elderly patients with heart failure. Eur J Heart Failure 7:411–417
Hage, C., Mattsson, E., Stahle, A. 2003. Long-term effects of exercise training on physical activity level and quality of life in elderly coronary patients – three- to six-year follow-up. Physiother Res Int 8:13–22
Lavie, C. J., Milani, R.V. 1996. Effects of cardiac rehabilitation and exercise training programs in patients > or = 75 years of age. Am J Cardiol 78:675–677
Williams, M.A., Fleg, J. L., Ades, P. A., Chaitman, B.R., Miller, N. H., Mohiuddin, S. M., Ockene, I. S., Taylor, C. B., Wenger, N.K. 2002. Secondary prevention of coronary heart disease in the elderly (with emphasis on patients > or = 75 years of age): an American Heart Association scientific statement from the Council on Clinical Cardiology Subcommittee on Exercise, Cardiac rehabilitation, and Prevention. Circulation 105:1735–1743
Sozialgesetzbuch; http://www.sozialgesetzbuchbundessozialhilfegesetz.de/
SGB IX: Neues Fundament für die medizinische Rehabilitation. 2003. Klinische Verhaltensmedizin und Rehabilitation 63:244–252
Bundesarbeitsgemeinschaft für Rehabilitation (BAR Frankfurt). 2005. Rahmenempfehlungen zur ambulanten kardiologischen Rehabilitation.
Cleland, J. G.F, Cohen-Solal Aguilar, J. C. Dietz, R., Eastaugh, J., Follath, F., Freemantle, N., Gavazzi, A., van Gilst, W. H., Hobbs, F.D.R., Korewicki, J., Madeira, H. C., Preda, I., Swedberg, K., Widimsky, J. for the IMPROVEMENT of Heart Failure Programme Committees and Investigators. 2002. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey. Lancet 360:1631–1639
Beckmann, U., Pallenberg, C., und Klosterhuis, H. 2000. Berichte zur Qualitätssicherung. Die Angestelltenversicherung 3:88-89
Müller-Fahrnow, W., Spyra, K., Egner, U. 2005. Qualitätssicherung (QS) und Qualitätsmanagement (QM). Rehabilitation und Teilhabe: 33–39
Verband Deutscher Rentenversicherungsträger. 2000. Das Qualitätssicherungsprogramm der gesetzlichen Rentenversicherung in der medizinischen Rehabilitation, Instrumente und Verfahren. DRV-Schriften 18
Wachtell, K., Lehto, M., Gerdts, E., Olsen, M.H., Hornestam, B., Dahlöf, B., Ibsen, H., Julius, S., Kjeldsen. S. E., Lindholm, L. H., Nieminen, M.S., Devereux, R. B. 2005. Angiotensin II receptor blockade reduces newonset atrial fibrillation and subsequent stroke compared to atenolol. The Losartan Intervention For End point reduction in hypertension (LIFE) study. J Am Coll Cardiol 45:712–719
Dahlöf, B., Sever, P. S., Poulter, N.R., Wedel, H., Beevers, D. G., Caulfield, M., Collins, R., Kjeldsen, S. E., Kristinsson, A., McInnes, G.T., Mehlsen, J., Nieminen, M., O'Brien, E., Ostergren, J., for the ASCOT Investigators. 2005. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outsomes Trial – Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomized controlled trial. Lancet 366:895–906
Tabacova, S., Little, R., Tsong, Y., Vega, A., Kimmel, C. A. 2003. Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment. Pharmacoepidemiology and drug safety 12:633–646
Alwan, S., Polifka, J. E., Friedman, J.M. Angiotensin II receptor antagonist treatment during pregnancy. Birth defects research. Part A, Clinical and molecular teratology 73:123–130
Collins, R., Armitage, J., Parish, S., Sleigh, P., Peto, R., for the Heart Protection Study Collaborative Group. 2005. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 361:2005–2016
Bruckenberger, E., Herzbericht 2005 mit Transplantationschirurgie. ISBN- 10:3-00-019729-X/ISBN-13:978-3-00- 019729-1; http://www.herzbericht.de
Deutsche Rentenversicherung. 2006. Leitlinie für die Rehabilitation bei koronarer Herzkrankheit. Modulare Therapiestandards zur Reha-Qualitätssicherung. www.deutsche-rentenversicherung.de
Deutsches Instrument zur methodischen Leitlinien-Bewertung (DELBI). http://www.versorgungsleitlinien.de/methodik/delbi/delbiindex
Carter, J. B., Banister, E.W., Blaber, A.P. 2003. Effect of endurance exercise on autonomic control of heart rate. Sports medicine 33:33–46
Iwasaki, K., Zhyng, R., Zuckerman, J. H., Levine, B.D. 2003. Dose-response relationship of the cardiovascular adaption to endurance training in healthy adults: how much training for what benefit? J Appl Physiol 95:1575–1583
Gielen, S., Adams, V., Möbius-Winkler, S., Linke, A., Erbs, S., Yu, J., Kempf, W., Schubert, A., Schuler, G., Hambrecht, R. 2003. Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure. J Am Coll Cardiol 42:861–868
Dickens, C. M., McGowan, L., Percival, C. 2006. Contribution of depression and anxiety to impaired health-related quality of life following first myocardial infarction. Br J Psychiatry 189:367–372
Petch, M.C. 1998. Task Force report: Driving and heart disease. Eur Heart J 19:1165–1177
Leitlinien der Deutschen Gesellschaft für Sozialmedizin und Prävention: sozialmedizinische Leistungsbeurteilung bei koronarer Herzkrankheit – Leitlinien für den beratungsärztlichen Dienst der Deutschen Rentenversicherung Bund. AWMF-Leitlinien-Register Nr. 074/003, Version 2005; AWMF online. http://leitlinien.net/
Author information
Authors and Affiliations
Corresponding author
Additional information
Deutsche Gesellschaft für Prävention und Rehabilitation von Herz-Kreislauferkrankungen e.V. (DGPR) in Zusammenarbeit mit der Deutschen Gesellschaft für Rehabilitationswissenschaften e.V. (DGRW) und der Deutschen Gesellschaft für Sportmedizin und Prävention e.V. (DGSP)
Unter Mitarbeit von:
Stephan Böhmen
Kardiologische Abteilung, Reha-Zentrum Oldenburg, Oldenburg
Gerd Bönner · Christian Holubarsch
MEDIAN Kliniken Bad Krozingen, Klinik Lazariterhof/Klinik Baden – Privatklinik, Bad Krozingen
Curt Diehm
Innere Medizin, Klinikum Karlsbad-Langensteinbach, Karlsbad
Hermann Faller
Institut für Psychotherapie und medizinische Psychologie, Universität Würzburg
Helmut Gohlke · Christa Gohlke-Bärwolf Wolfgang Langosch
Herzzentrum Bad Krozingen, Bad Krozingen
Gesine Grande
Hochschule für Technik, Wirtschaft und Kultur (HTWK), Leipzig
Klaus Götzmann
Postfach 468, Waldkirch bei Freiburg
Harry Hahmann
Klinik Schwabenland, Isny-Neutrauchburg
Rainer Hambrecht
Klinik für Kardiologie, Klinikum Links der Weser, Bremen
Christoph Herrmann-Lingen
Klinik für Psychosomatische Medizin und Psychotherapie, Universität Marburg
Stephan Jacob
Forum für Vaskuläre Medizin, Brombeerweg 6, Villingen-Schwenningen
Ulrich Keil
Institut für Epidemiologie und Sozialmedizin, Universitätsklinikum Münster
Ellen Kuhlmann
Zentrum für Sozialpolitik, Abt. Geschlechterpolitik im Wohlfahrtsstaat, Uni Bremen
Wolfgang Mayer-Berger
Klinik Roderbirken der Deutschen Rentenversicherung Rheinland, Leichlingen
Olaf Schulz
Kardiologische Praxisgemeinschaft am Klinikum Spandau, Berlin
Joachim Thiery
Institut für Laboratoriumsmedizin, Klinische Chemie und Molekulare Diagnostik, Universitätsklinikum Leipzig, Leipzig
Diethelm Tschöpe
Herz- und Diabeteszentrum NRW, Bad Oeynhausen
Helmut Teschler
Abt. Pneumologie, Ruhrlandklinik – Universitätsklinik, Essen
Claudia Wilhelm
Klinik Falkenburg, Bad Herrenalb
Alfred Wirth
Teutoburger-Wald-Klinik, Bad Rothenfelde
Horst Zebe
Am Unterscheid 2, Bad Wildungen
Redaktionelle Assistenz:
Kristina Korinth · Erika Winterhalter
Deutsche Gesellschaft für Prävention und Rehabilitation von Herz-Kreislauferkrankungen e.V., DGPR
Rights and permissions
About this article
Cite this article
Bjarnason-Wehrens, B., Held, K., Hoberg, E. et al. Deutsche Leitlinie zur Rehabilitation von Patienten mit Herz-Kreislauferkrankungen (DLL-KardReha). Clin Res Cardiol Suppl 2 (Suppl 3), III1–III54 (2007). https://doi.org/10.1007/s11789-007-0001-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11789-007-0001-0